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1 Introduction 
 
 
1.1 Aquaporins 
 
1.1.1 Discovery of aquaporins 
 
The cell, the basic unit of life, is essentially defined by its plasma membrane. The cell plasma 
membrane is a major barrier for the free movement of solvents. Its main purpose is to divide 
the intracellular content from the extracellular fluid. During cell evolution, specific channels 
evolved to transport nutrients, metabolic products etc. in and out of the cell. 
The major component of a cell is water. The hydrophobic plasma membrane presents a 
significant energy barrier for water movement into and out of the cells. Water can diffuse 
across lipid bilayer membranes, although the activation energy (Ea) required for this process 
to occur is much greater than for diffusion (10-20 vs. 5 kcal mol-1; Heymann et al., 1999). 
However, studies on water flow through mammalian red blood cell membranes demonstrated 
that it occurs with an Ea of <5 kcal/mol whereas diffusion of water through pure lipid 
membranes occurs with a higher activation energy (Ea >10 kcal/mol; Engel et al., 2001). 
Furthermore, the high water permeability of mammalian red blood cells to water is strongly 
inhibited by mercuric chloride (HgCl2). In addition, experiments with amphibian skin have 
shown that some epithelia are extremely “leaky” to water.  
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All together, these findings led to early speculations that beside simple diffusion water may 
enter the cell in an assisted manner probably through proteins that conduct water.  
About one decade ago, Peter Agre showed that specific water channels (aquaporins) are 
indeed present in erythrocytes. Originally, this channel protein was named CHIP28. It was the  
first member of the aquaporin (AQP) family and was subsequently renamed to AQP1 (Preston 
et al., 1992). 
To date the aquaporin family comprises more than 450 members (Zardoya et al., 2005) from 
all kingdoms of life e.g. from bacteria, protozoa, plants and animals. Thirteen aquaporins have 
been identified in humans designated as AQP0-12. 
The aquaporin family consists of two major subfamilies: water specific channels (orthodox 
aquaporins) and channels which are permeable for glycerol, water and other small molecules 
(aquaglyceroporins).  
AQP1 is the prototype of the orthodox aquaporins and it is exclusively permeable for water 
molecules (Sui et al. 2001). The E. coli GlpF, a prototypical aquaglyceroporin, has high 
permeability to glycerol, but low permeability to water (Fu et al., 2000). 
 
 
1.1.2 Structural organisation of aquaporins 
 
Initial inspection of the primary sequence of aquaporin AQP1 suggested that the protein 
consists of six α-helical transmembrane domains with an inverted symmetry between the first 
three and last three domains. The two loops between helix 2-3 and helix 5-6 contain an amino 
acid triplet Asn-Pro-Ala (NPA motif) which is highly conserved across the members of the 
aquaporin family (Fig. 1.1. A).  
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It was thought, that the six bilayer spanning helixes surround a water pore with two conserved 
NPA motifs in the middle (Fig. 1.1. B; Preston et al., 1992; Jung et al., 1994; Borgnia et al., 
1999). This topology was named “hour glass” model. This “hour glass” conformation was 
later confirmed using X-ray crystallography (Sui et al., 2001). The functional unit of 
aquaporins is a tetramer with an independent water pore in each subunit.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1. Aquaporin-1 membrane topology and hourglass model. A: Aquaporin-1 contains six bilayer-   
spanning domains composed of two inversely symmetrical structures (first hemipore and second hemipore) and  
five loops (A, B, C, D, E) where loops A and C are extracellular, D is intracellular and B and E fold back into the 
membrane. N and C termini are intracellular.  B: The NPA triads in loops B and E form a single aqueous 
pathway through the membrane. 
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Primary sequence analysis showed specific differences between aquaglyceroporins and 
orthodox aquaporins, such as the motive GLYY (Fig. 1.2., shaded in green) in the C-loop and 
an aspartate residue after the second NPA motif (NPARD) which are typical for 
aquaglyceroporins. In orthodox aquaporins the second NPA motif if followed by a serine 
(NPARS) (Fig. 1.2., shaded in yellow; Borgnia et al., 1999).  
Another discrimination between aquaporins and aquaglyceroporins is the length of the 
extracellular C-loop which is about 15 amino acids longer in aquaglyceroporins (Engel et al., 
2000; Beitz et al., 2004). Furthermore, the C-loop amino acid triad F[A/S]T is highly 
conserved in aquaglyceroporins (Beitz et al., 2004; Fig. 1.2. shaded in violet). In PfAQP this 
triad corresponds to a WET triplet with a highly conserved Thr. A marked difference between 
the WET and F[A/S]T motifs is the presence of  a negatively charged Glu at the second 
position which might interact with a positively charged Arg in the pore constriction 
region.When the atomic structures of both, human orthodox aquaporin AQP1 and bacterial 
aquaglyceroporin GlpF, were reported, they revealed a surprising structural similarity (Beitz 
et al., 2004). 
A few years ago, our group identified a single aquaglyceroporin in Plasmodium falciparum 
parasites (PfAQP; Hansen et al., 2002). The primary sequence suggested that the newly 
identified protein is an aquaglyceroporin with close a relationship to the E. coli GlpF. 
However, the characteristic NPA motifs are changed to NLA and NPS in the P. falciparum 
aquaporin (Fig. 1.2. shaded in red). Functional characterisation showed that this aquaporin has 
high water and glycerol permeability (Hansen et al., 2002).  
Based on the GlpF structure PfAQP was modelled revealing that the amino acids of the pore 
constriction are identical to those of GlpF (Fig. 1.3.). Furthermore, the RD after NPS and  
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GLYY motifs which are characteristic for aquaglyceroporins, are present in PfAQP (Fig. 
1.2.). However, the C-loop is shorter in PfAQP (13 aa) than in GlpF which is reminiscent of 
orthodox aquaporins.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2. Sequence alignment of human aquaporin-1 (AQP1), human aquaglyceroporin-3 (AQP3), E. coli 
aquaglyceroporin (GlpF) and P. falciparum aquaglyceroporin (PfAQP). The NPA motifs are coloured in 
red, F[A/S]T-WET triad is coloured in pink, GLYY is coloured in green and D or S after the second NPA 
motif is coloured in yellow. The alignment was generated using ClustalV. 
 
                                                                      
                      *        20         *        40         *       
AQP1       : MA--SEFKKKLFW--RAVVAEFLATTLFVFISIGSALGFKYPVGNNQTAV :  46 
AQP3       : MNRCGEMLHIRYRLLRQALAECLGTLILVMFGCGSVAQVVLSRGTHG--- :  47 
GlpF       : MSQTST-------LKGQCIAEFLGTGLLIFFGVGCVAALKVAGASFG--- :  40 
PfAQP      : MHM---LFYKSY--VREFIGEFLGTFVLMFLGEGATANFH-TTGLSG--- :  41 
                                                                      
                                                                      
                     60         *        80         *       100       
AQP1       : QDNVKVSLAFGLSIATLAQSVGHISGAHLNPAVTLGL-LLSC---QISIF :  92 
AQP3       : -GFLTINLAFGFAVTLAILVAGQVSGAHLNPAVTFAM----CFLAREPWI :  92 
GlpF       : -QW-EISVIWGLGVAMAIYLTAGVSGAHLNPAVTIALWLFACFDKR---- :  84 
PfAQP      : -DWYKLCLGWGLAVFFGILVSAKLSGAHLNLAVSIGLSSINKFDLK---- :  86 
                                                                      
                                                                      
                      *       120         *       140         *       
AQP1       : RALMYIIAQCVGAIVATAILSGI----------TSSLTGNSLGRNDLADG : 132 
AQP3       : KLPIYTLAQTLGAFLGAGIVFGLYYDAIWAFAGNELVVSGPNGT---AGI : 139 
GlpF       : KVIPFIVSQVAGAFCAAALVYGLYYNLFFDFEQTHHIVRGSVESVDLAGT : 134 
PfAQP      : KIPVYFFAQLLGAFVGTSTVYGLYHGFISNSKIPQFA------------- : 123 
                                                                      
                                                                      
                    160         *       180         *       200       
AQP1       : --------VNSGQGLGIEIIGTLQLVLCVLATTDRRRRDL--GGSAPLAI : 172 
AQP3       : FATYPSGHLDMVNGFFDQFIGTAALIVCVLAIVDPYNNPVPRG-LEAFTV : 188 
GlpF       : FSTYPNPHINFVQAFAVEMVITAILMGLILALTVD-GNGVPRGPLAPLLI : 183 
PfAQP      : WETSRNPSISLTGAFFNELILTGILLLVILVVVDENICGKFHILKLSSVV : 173 
                                                                      
                                                                      
                      *       220         *       240         *       
AQP1       : GLSVALGHLLAIDYTGCGINPARSFGSAVIT-------HNFSNH------ : 209 
AQP3       : GLVVLVIGTSMGFNSGYAVNPARDFGPRLFTALAGWGSEVFTTGQN--WW : 236 
GlpF       : GLLIAVIGASMGPLTGFAMNPARDFGPKVFAWLAGWGNVAFTGGRDIPYF : 233 
PfAQP      : GLIILCIGITFGGNTGFALNPSRDLGSR-FLSLIAYGKDTFT--KDNFYF : 220 
                                                                      
                                                                      
                    260         *       280         *       300       
AQP1       : WIFWVGPFIGGALAVLIYDFILAPRSSDLTDRVKVWTSGQVEEYDLDADD : 259 
AQP3       : WVPIVSPLLGSIGGVFVYQLMIGCHLEQ--------PPPSTEAENVKLAH : 278 
GlpF       : LVPLFGPIVGAIVGAFAYRKLIGRHL-P--------CDICVVEEKETTTP : 274 
PfAQP      : WVPLVAPCVGSVVFCQFYDKVI--------------CPLVDLANNEK--- : 253 
                                                                      
                              
                      *       
AQP1       : INSRVEMKPK : 269 
AQP3       : MKHKEQI--- : 285 
GlpF       : SEQKASL--- : 281 
PfAQP      : --DGVDL--- : 258 
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It was shown that the C-loop has an important role in water permeability in PfAQP (Beitz et 
al., 2004). Introduction of a mutation into the WET triad which is an analogue to FST in the 
GlpF C-loop, (glutamate to serine, PfAQP E125S), resulted in a high reduction of water 
permeability (Fig. 1.3.). A possible explanation may be that Glu125 interacts with Arg196 
and interruption of this interaction influences on water permeability. 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3. Schematic presentation of the outer pore constriction in E. coli GlpF and PfAQP as viewed from 
the extracellular side.  
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1.1.3 Parasite aquaporins 
 
Malaria, toxoplasmosis and Chagas' disease are infectious diseases caused by protozoa that 
affect more than 300-400 million people around the world and represent a major health 
problem in developing countries (Gelb et al., 2002). Because of the high infection rate and 
rapid development of drug resistant parasite strains, new strategies for drug development are 
needed.  
Parasites from the phylum Apicomplexa and Euglenozoa (genus Kinetoplastida) are particular 
human pathogenic (Baldauf et al. 2000; Beitz et al., 2005).  
The phylum Apicomplexa includes a large number of obligate intracellular parasites, among 
which are the human pathogens Plasmodium (malaria), Toxoplasma (AIDS related 
encephalitis), Cryptosporidium and Cyclospora (severe enteritis) as well as many parasites of 
veterinary importance (Eimeria, Theileria, Sarcocystis and Babesia).  
The parasite life cycles can be relatively simple, involving only a single host 
(Cryptosporidium), whereas the others require interspecies transmission often between an 
insect and a mammal (Beitz et al., 2005, Roos et al., 2005). Some parasites are specialists, 
restricted to special species and tissues, e.g. Plasmodium falciparum, the others are more 
general and can infect almost any tissue of warm blooded animals, e.g. Toxoplasma gondii.  
A characteristic organelle for all apicomplexan parasites is the apicoplast. It is postulated that 
apicomplexan parasite have acquired this organelle by the ingestion of an eucaryotic plastid 
containing alga (plastid of red alga and euglenoids; Dzierszinski et al., 1999).  
Genome analysis showed that P. falciparum expresses only one aquaporin whereas 
Kinetoplastida parasites (Trypanosoma cruzi, Trypanosoma brucei and Leishmania major) 
 
 
 
Introduction 
 8
 
express from 3 to 5 aquaporins. Interestingly in the Cryptosporidium parvum genome no 
aquaporin gene was found at all (Beitz et al., 2005).  
 
1.2 Plasmodium falciparum 
 
It is estimated that there are around 300 million cases of malaria world-wide and up to 2.7 
million deaths from malaria each year. Four species of malaria are infectious for humans: P. 
falciparum, P. vivax, P. malariae and P. ovale.  P. falciparum is the most lethal species for 
humans. 
Malaria parasites enter their vertebrate host via the bite of an infected Anopheles mosquito.  
Via the blood stream the parasites (sporozoites) first invade liver cells. Within two days, up to 
32 new merozoites are released into the blood stream, where they are about to invade the red 
blood cells of their host.  
The different stages of the asexual intra-erythrocytic phase of the parasite life cycle are 
schematically represented in Fig. 1.3.  First, the malaria parasite invades an erythrocyte and 
during this process the parasite is being enclosed with a so-called parasitophorus vacuole 
membrane (PVM) (Fig. 1.3. a). Approximately, during the initial 15 hours after invasion (the 
so-called “ring” stage) the parasite presumably lies dormant (Fig. 1.3. b). There is a 
progressive increase in metabolic activity 15 h after invasion when parasites enter the 
trophozoite stage (Fig. 1.3. c).  
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Fig. 1.4. Schematic representation of the different stages of the asexual erythrocyte phase of the life cycle 
of the malaria parasite P. falciparum. a: invasion a merozoite. b: represents “ring” stage.  c: trophozoite stage. 
d: schizont stage. e: the host erythrocyte bursts and releases merozoites and a new cycle begins. 
 
 
 
Protein, RNA and DNA synthesis is extensive in this stage of intra-erythrocytic development. 
Due to the fact that malaria parasites lack a functional citric acid cycle, their energy supply is 
fully dependent on glycolysis. During parasite growth glucose utilisation and lactate 
production is increased by up to 100 times the rate of uninfected erythrocytes (Roth et al., 
1988). 
 
 
a 
b 
c d 
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Through the process of endocytosis, host proteins, especially haemoglobin, are internalised 
and further digested to small peptides and amino acids in the food vacuole and subsequently 
used for protein synthesis.  
Protein degradation is accompanied by ammonia production. Due to the high level of 
haemoglobin degradation toxic ammonia has to be released or converted into a less toxic 
compound like urea. Inspection of the P. falciparum genome did not reveal sequences of any 
enzyme involved in the urea cycle except for arginase. From this information the question 
arose at which rate ammonia is produced during the erythrocytic stage of parasite 
development and how it is released. 
About 36 h post invasion the parasite occupies approximately one third of the total volume of 
the host cell. Approximately 40 h after the trophozoite stage the parasite enters the “schizont” 
stage (Fig. 3 d). 
At this stage, the parasite subdivides into 20-32 daughter merozoites. At “schizogony” the 
host cell ruptures and parasites are released (Fig. 3 e). This happens 48 h after invasion of the 
host erythrocyte.  
During its life cycle the malaria parasite faces drastic osmotic changes during kidney 
passages. Further, there is the need for massive biosynthesis of glycerolipids during 
development in the blood stage because of fast growth and division (Hansen et al., 2002). 
PfAQP may facilitate rapid water movement during kidney passage and thus protect the 
parasite’s membrane integrity. It may further provide access to the serum glycerol as a 
precursor for lipid biosynthesis during the parasite development in the intraerythrocytic stage.  
Channels and transporters play a central role in parasite survival within the host organism. 
Hence, they are interesting as potential drug targets or may be used as uptake routes of 
cytotoxic drugs into the parasite cell. 
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The physiological function of PfAQP is unknown. One aim of this work is to characterise its 
permeability properties which may give hints on its physiological function. 
 
 
1.2.1 GAPDH enzyme, possible roles in the cell  
 
Glucose is the sole energy source of malaria parasites. Ten catalytic steps convert glucose to 
pyruvate to produce 2 mols ATP per mol of glucose. Conversion of glyceraldehyde-3-
phosphate to 1,3-bisphosphoglycerate in the presence of NAD+ and inorganic phosphate  is 
catalyzed by glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The GAPDH enzyme is 
a homotetramer with a molecular mass of approximately 150 kDa (Fig. 1.5). Each subunit is 
composed of an N-terminal NAD+ binding domain and a C-terminal catalytic domain (Cown-
Jacob et al., 2003). The NAD+ binding domain is conserved among various dehydrogenases 
(Rossman fold), but the structural changes in the adenosine binding pocket of Leishmania 
mexicana GAPDH can be used as a specific drug target (Bressi et al., 2001; Suresh et al., 
2001). 
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Fig. 1.5. Structure of the GAPDH homotramer. (This was prepared using PyMOL). GAPDH is a tetramer 
composed of four identical polypeptide chains which are coloured in pink, violet, green and yellow.  
. 
Besides numerous other GAPDH structures from various species, the P. falciparum GAPDH 
structure has recently been resolved (Satchell et al., 2005).  
Historically, mammalian GAPDH was considered as an enzyme involved in glycolysis with 
its main role in energy metabolism. Expression levels of the GAPDH remain constant under 
most experimental conditions and it has been frequently used as an internal control for 
studying the regulation of expression of other genes. 
Independent from the traditional role in glycolysis, GAPDH is a protein with multiple 
intracellular localisations and diverse activities (Sirover et al., 1999). These new activities 
include regulation of the cytoskeleton, membrane fusion and function, export of nuclear 
RNA, DNA reparation and, particularly intriguing, apoptosis. It is not clear whether 
PfGAPDH has additional functions in parasites besides in glycolysis. 
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1.3 Toxoplasma gondii 
 
Toxoplasmosis is an infectious disease caused by the protozoan T. gondii which is, as 
Plasmodium, a member of the protozoan phylum Apicomplexa. Infections by T. gondii infect 
humans and animals world wide.  Under certain conditions, toxoplasmosis can cause serious 
pathology; especially in individuals whose immune systems are compromised, e.g., AIDS 
patients.  
While Plasmodium parasites multiply exclusively in the erythrocytes and liver cells, 
Toxoplasma gondii invades various cell types. The T. gondii genome is sequenced 
(www.tigr.org).  
 
 
1.4 Trypanosoma brucei 
 
Trypanosomatids like Apicomplexan parasites are frequent topics of research for two reasons: 
their pathogenicity and divergent biology. Among others, tripanomatids include African 
Trypanosomes (T. brucei), American trypanosomes (T. cruzi), and Leishmania spp. which 
cause  chronic, often fatal diseases in humans. 
The life cycle of T. brucei parasites includes two different stages: i.e., the long slender form in 
the blood, lymphatic fluids and in the cerebrospinal fluid of its mammalian host and the 
procyclic form in the mid gut of the tsetse fly.  
In the mammalian bloodstream T. brucei has neither a functional Krebs cycle nor oxidative 
phosphorylation nor does it store any carbohydrates. Consequently, the energy metabolism of  
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T. brucei depends totally on glycolysis with glycerol as an alternative substrate (Bakker et al., 
1997). It was reported that due to the differences between mammalian and trypanosomal 
glycolysis this pathway is a potential drug target for drug design against African sleeping 
sickness (Michels et al., 1998). The first seven glycolytic reactions of glycolysis in 
trypanosomes are placed in a peroxisome like organelle, the so-called glycosome (Parsons et 
al., 2004). The presence of a glycosome represents a connection to the plant kingdom similar 
to the apicoplast in Apicomplexan parasites. Accordingly, several plant-like proteins are 
present in the glycosome. 
Under aerobic conditions, in the glycosome glucose is converted to 3-phosphoglycerate which 
is metabolized into pyruvate in the cytosol. The NADH produced in the glycosome is used to 
reduce dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate (Gly-3-P). Further, Gly-
3-P is reoxydised by molecular oxygen via glycerol-3-phosphate oxidase in the mitochondria 
and DHAP is returned into the glycosome. Under anaerobic conditions, equimolar amounts of 
pyruvate and glycerol are produced. Glycerol has to be rapidly exported out of the glycosome 
otherwise it has a toxic effect on the parasite. Suppression of glycolysis by inhibiting the 
release of glycerol or pyruvate is a potential therapeutic approach against sleeping sickness 
(Bakker et al.,1997).   
 
 
The aim of this work was to characterise protozoan aquaporins (P. falciparum, T. gondii and 
T. brucei) in order to obtain information about the water and solute permeability profile, the 
possible pore size, the similarities and differences between these and other aquaporins. From 
such functional properties physiological functions may be derived. 
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2 Materials 
 
 
2.1 Enzymes, kits and chemicals 
 
Ambion, Austin (USA): mMessage mMachine Transcription Kit 
Amersham Pharmacia Biotech, Freiburg: ECL Plus Western Blot Detection System, 
Hyperfilm ECL, Thermosequenase Fluorescent Labelled Primer Cycle Sequencing Kit with 
7-deaza-dGTP 
AppliChem, Darmstadt: HEPES, Acrylamide 4K-Solution 30 % 
Appligene, Heidelberg: Taq DNA polymerase with 10× reaction buffer 
Biogenes, Berlin: C-terminal hexadekapeptid (CPLVDLANNEKDGVDL) from PfAQP, 
rabbit anti-serum against this peptide 
BIO-RAD, München: BIO-RAD Protein-Assay Dye Reagent Concentrate 
Celllabs, Brookvale (Australia): Malaria Ag CELISA 
Dianova, Hamburg: Goat anti-mouse antibodies horseradish peroxidase conjugated, goat 
anti-rabbit antibodies horseradish peroxidase conjugated 
Macherey-Nagel, Düren: Nucleotrap 
Merck, Darstadt: Imidazole, glycine, sodium acetate, glucose, sodium hydrogenphosphate, 
sodium chloride. 
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Millipore, Molsheim (France): QTUOO EX, QUANRUM EX 
MWG-Biotech, Ebersberg: Oligonucleotides 
New England Biolabs, Schwalbach/Taunus: Restriction endonuclease, BSA, T4-
Polynucleotide kinase, 10× Kinase buffer. 
Peqlab, Erlangen: Agarose, peqGOLD Protein Marker 
Promega, Madison: Wizard MiniPreps Plasmid Purification Kit 
Qiagen, Hilden: Ni2+-NTA-Agarose, pQE Expression vector, purified mouse monoclonal 
RGS-His antibody (BSA free), QIAamp DNA Blood Mini kit 
Roche (Boeringer), Mannheim: Restriction endonucleases, Klenow-polymerase, alkaline 
phosphatase, Rapid DNA Ligation Kit, dNTP΄s, Complete Protease Inhibitor Cocktail Tablets 
Sartorius, Göttingen: Cellulose acetate filter with pore size 0.2 µm 
SERVA Electrophoresis, Heilderberg: Coomassie-Brilliant-blue G250, VISKING dialysis 
Tubing 8/32 and 27/32 with MW 12000-14000 
Sigma, Deisenhofen: Glycerol, TRIS, EDTA, Xgal, IPTG, Ponceau S, Tween 20, TEMED, 
BSA, dihydroxyacetone, methylglyoxal, RPMI 1640 medium, Giemsa solution, sorbitol 
Stratagene, Heidelberg: Plasmid pBluescript II SK (-), E. Coli XL1- Blue MRF- 
 
 
2.2 Equipment and materials 
 
Amersham Pharmacia Biotech, Freiburg: Electrophoresis power-supply EPS 3500  
Bender and Hobein, Ulm: Vortex Genie 2 
Biometra, Göttingen: TRIO-Thermoblock thermocycler 
BIO-RAD, München: Trans-Blot SD Semi Dry Transfer Cell 
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BIO-RAD, München: Trans-Blot SD Semi Dry Transfer Cell 
Branson, Danbury (USA): Sonifier B-12 
Eberhard-Karls-Universität, Tübingen: Chambers for gel electrophoresis 
Eppendorf, Hamburg: Table centrifuges 5410 & 5414, cooling centrifuge 5402, 
BioPhotometer  
Hybaid, London (GB): Mini Oven MK II 
Kähler, Hamburg: Xenopus laevis females  
Knauer, Berlin: Semi-Micro-Osmometer 
Kodak, New Haven (USA): Biomax MR X-ray films 
Kontron-Hermle, Gosheim: Centrikon h401 & ZK 401, Rotor SS34 
Leica, Germany: Leica MZ6 microscope 
Macherey-Nagel, Düren: Porablot PDVF-Blotting membrane (0.2 µm pore size) 
Millipore, Eschborn: Water purification system MilliQ UF Plus 
MWG-Biotech, Ebersberg: LI-COR DNA sequencer model 4000 
Sartorius, Göttingen: Balance BP 2100 S, analytic balance handy  
Savant, Farmingdale (USA): Vacuum centrifuge speed vac concentrator SVC100H 
Schleicher & Schuell, Dassel: Whatmanpaper 3 MM, Protran BA83 Cellulosenitrate 0.2 µm  
Blottingmembrane 
Shimadzu, Kyoto (Japan): UV-VIS spectrophotometer UV-1202 
Stratagene, Austin (USA): UV Stratalinker 2400  
WPI, Sarasota (USA): Nanoliter-Injector, binocular microscope  
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2.3 Buffers and solutions  
 
2.3.1 Molecular biology 
 
 
2.3.1.1 DNA electrophoresis 
 
TAE-buffer                                                                           TBE-buffer 
40 mM    TRIS-acetate, pH 8.0                                             100 mM    TRIS 
  1 mM    Na2EDTA                                                                80 mM    Boric acid 
                                                                                                25 mM     Na2EDTA 
 
 
 
BX-sample buffer  
   0.5 %    Bromphenolblue   
   0.5 %    Xylencyanol  
      5 %    Glycerol 
 
 
2.3.1.2 Reaction buffers 
 
Klenow buffer   (10×)                                                        Dephosphrylation buffer 
200 mM    TRIS-HCl, pH 7.9                                                500 mM     TRIS-HCl, pH 8.5 
  60 mM    MgCl2                                                                                                          1 mM      EDTA 
  10 mM    DTT 
1 mg/ml    BSA 
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2.3.1.3 Media for E. coli cultures 
 
LB medium                                                               LB-Agar plates                                    
       10 g/l      Bacto trypton                                          15 g/l   agar in LB medium                                          
       10 g/l      NaCl 
         5 g/l      Yeast extract                                        LB-Agar plates with ampicillin 
                                                                                    100 µg    ampicillin/ml LB medium        
 LB medium with antibiotics                                                      LB medium with agar   
100 µg/ml     ampicillin and/or                                                                                      
  50 µg/ml     kanamycin                                          LB-Agar plates with kanamycin 
                                                                                       50 µg    kanamycin/ml LB medium        
                                                                                                    LB medium with agar   
 
2.3.1.4 Transformation of E. coli          
 
 
CM-buffer         
   100 mM     CaCl2 
   100 mM     MgCl2  
Solution was sterilised by sterile filtration (pore size 0.2 µm) 
 
 
2.3.1.5 DNA precipitation and purification 
 
          3 M    Na-acetate buffer (stored at room temperature) 
        98 %     EtOH                    (stored at -25°C) 
        70 %     EtOH                    (stored at -25°C) 
 
 
2.3.2 Protein chemistry  
 
 
2.3.2.1 Protein purification  
 
Lysis buffer 
     50 mM      TRIS-HCl, pH 8.0 
     10 mM      DTT 
 
Washing buffer  
     50 mM      TRIS-HCl, pH 8.0 
   300 mM      NaCl 
     10 mM      Imidazole 
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  30 mM          Imidazole 
  10 mM          DTT 
 
 
Elution buffer 
  50 mM          TRIS-HCl, pH 8.0 
300 mM          NaCl 
150 mM          Imidazole 
  10 mM          DTT 
    1 mM          NAD+ 
 
Hypotonic phosphate buffer 
 7.5 mM          Na2HPO4  pH7. 5 
with protease inhibitors cocktail 
 
 
 
2.3.2.2 SDS-Polyacrylamide gel electrophoresis 
 
 
Running gel buffer                                                                  Stacking gel buffer                 
    1.5 M          TRIS-HCl, pH 8.8                                                0.5 M      TRIS-HCl, pH=6.8    
     0.4%          SDS                                                                        0.4%       SDS 
   
 
 
Electrophoresis buffer  
  25 mM           TRIS-HCl, pH 8.3 
192 mM           glycin 
     0.1%           SDS 
 
Protein sample buffer (4×) 
130 mM           TRIS-HCl, pH 6.8 
      10%            SDS 
      10%            β-mercaptoethanol 
      20%            glycerol 
   0.06%            bromphenolblue 
        2%            LiDS 
 
Coomassie staining solution                                                   Destaining solution 
       0.2%          Coomassie Brilliant-Blue G 250                         10 %      acetic acid                 
        10%          acetic acid                                                            30 %      EtOH 
        50%          methanol 
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2.3.2.3 Western blot 
 
Towbin buffer                                                                      TBS-buffer   
    25 mM     TRIS-HCl, pH 7.5                                            50 mM      TRIS-HCl 
  192 mM     Glycin                                                             150 mM      NaCl 
       29 %      Methanol 
0.0375 %      SDS 
 
 
M-TBS                                                                                 TBS-T                                                                        
          5%      milk   powder in TBS buffer                                0.1 %     Tween 20 in TBS 
 
 
 
 
 
2.3.2.4 Medium for Xenopus oocytes    
 
 
ND96                                                                                  OR-2 
   96 mM        NaCl                                                                82.5 mM      NaCl 
     2 mM        KCl                                                                       2 mM      KCl 
  1.8 mM        CaCl2                                                                    1 mM      MgCl2 
     1 mM        MgCl2                                                                                                    5 mM      HEPES, pH = 7.4 
     5 mM        HEPES, pH 7.4 
 
These solutions were sterilised by autoclaving for more than 20 min at 121°C and 1 bar. 
 
 
 
2.3.3 Media for Plasmodium falciparum cultures 
 
 
All solutions for parasite cultures were made under sterile conditions, and sterilised by 
autoclaving or sterile filtration (filter pore size 0.2 µm) 
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2.3.3.1 Complete RPMI 1640 medium with glucose 
 
RPMI 1640 medium (SIGMA 500 ml) 
20 µg/ml        gentamicin sulphate        
   25 mM        HEPES  
     2 mM        L-glutamine       
     10 ml        human serum 
   0.1 µM        hypoxanthine 
     50 ml        albumax (Albumax II, Gibco) 
                      store at 4°C 
 
 
 
2.3.3.2 Complete RPMI 1640 medium without glucose 
 
RPMI 1640 medium (Gibco 500 ml) without glucose: 
20 µg/ml        gentamicin sulfate        
   25 mM        HEPES  
     2 mM        L-glutamine       
     10 ml        human serum 
   0.1 µM        hypoxanthine 
     50 ml        albumax  II  (without glucose) 
                store at 4°C 
 
 
 
2.3.3.3 Albumax II  (10× concentrate) 
 
RPMI 1640 medium (with or without glucose) 
20 µg/ml        gentamicin sulfate        
   25 mM        HEPES  
     2 mM        L-glutamine       
     10 ml        human serum 
   0.1 µM        hypoxanthine 
      25 g          albumax II 
        pH          7.0-7.4 
                       store at -25°C 
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2.3.3.4 Solution for parasite synchronization 
 
         5%       sorbitol 
 
 
 
2.3.3.5 Giemsa staining of thin blood films 
 
        98%      methanol   
   6.7 mM      phosphate buffer pH 7.1 
                     Giemsa stain  
 
 
 
2.3.4 Buffers and solutions for enzyme assays 
 
2.3.4.1 GAPDH enzyme assay 
 
   50 mM      TRIS-HCl buffer, pH 8.0 
 300 mM      NaCl 
     1 mM      NAD+ 
   50 mM      Na2HPO4 
     10 mM      DTT 
  5 µg/ml      GAPDH 
 
 
 
2.3.4.2 Assay for ammonia determination 
 
 122 mM      TEA buffer, pH 8.0 
0.56 mM      ADP in TEA buffer 
     6 mM      NADPH in TEA buffer 
   71 mM      α-ketoglutarate in TEA buffer 
 7.4 U/ml       enzyme in TEA buffer          
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2.4 Primer list  
 
 
primers name sequence position restriction place 
PfAQPs 5'-actagatctcaatgcatatgtta-3' -11-12 Bgl II 
PfAQPF190Yas 5'ctggatcctaaatctcttgatgggttaagtg
catatcca -3' 
564 -602 BamH I 
PfGAPDHs 5'- tagcatgcatggcagtaacaaaac 
ttgg -3' 
1-20 Sph I 
PfGAPDHEcoRVs 5'-aagatatcgaagtagttgcta 
ttaacgac-3' 
65-86 EcoR V 
PfGAPDHas 5'-ggaagcttagttgttagtaat 
gtgtac-3' 
994-1014 HinD III 
Tg1AQPs1 5'-tagaattcgagtgagactgcttctatg-3' -23-3  EcoR I 
Tg1AQPas 5'-ttaagcttccgtgccgccgttca 
ctctt-3' 
1-28 HinD III 
Tg1AQPs2 5'-tagaattccgagcatctcatcttcaat-3' 96 -111  EcoR I 
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3 Methods 
 
 
3.1 Molecular biology methods 
 
 
3.1.1 Polymerase chain reaction (PCR) 
 
PCR was used to amplify fragments from plasmid or genomic DNA and for introduction of 
endonuclease restriction sites or point mutations. The DNA template (1-10 ng) was incubated 
with DNA polymerase (1-2 U), dNTPs (200 µM), and two oligonucleotide primers (each 200 
nM), whose sequences flank the DNA sequence of interest in a total reaction volume of 50 µl. 
The annealing temperature was calculated as follows:  
                                Tm=60 + 0.41 * %GC - 600 / n [for primers ≥25 bp] 
%GC represents percent of the GC content of the primer and n is the number of the bases of 
the primer   
                               Tm=2 * (AT) + 4 * (GC) - 4 [for primer ≤ 24 bp] 
AT and GC represent the number of A + T and G + C bases, respectively, in the primer 
sequence.  
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If the annealing temperature for the two primers of a PCR reaction was different, the lower 
annealing temperature was used.  
The reaction was done in a thermocycler with heatable lids to avoid volume and concentration 
changes. The temperature program used for the PCR reaction is shown in Table 3.1. 
 
 
 
Denaturation 95°C 5 min 
Denaturation 95°C 50 s 
Annealing Tm 50 s 
20-40 
cycles 
Extension 72°C 50 s 
Fill up 72°C 10 min 
 
                               Tabele 3.1 Program used for polymerase chain reaction 
 
 
 
3.1.2 DNA agarose gel electrophoresis  
 
DNA agarose gel electrophoresis was used to separate and isolate DNA fragments or to 
analyse the size of DNA fragments. 
0.5-1 g of agarose was added to 50 ml of TEA buffer and melted in a microwave oven. DNA 
samples were mixed with BX buffer (1:10), loaded on the agarose gel (1-2%, TEA buffer) 
and electrophoresis was performed in TEA buffer at 80-100 V for 1 h at room temperature. 
The size of the DNA fragments was determined using λ-Marker (EcoR I/HinD III digested λ-
phage DNA) and π-Marker (Msp I/Ssp I digested pBlueskript II SK(-)-vector). DNA fragment 
sizes of λ-Marker are 21226, 5184, 4973, 4277, 3530, 2027, 1904, 1584, 1330, 983, 831, 564, 
125 bp and π-Marker DNA fragments are: 489, 404, 312, 270, 242, 215, 190, 157, 147, 110, 
67, 57, 34, 26 bp. Detection of DNA was done by adding ethidium bromide (10 µg/100 ml) to  
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the gel solution. After electrophoresis, DNA was visualised in UV light (302 nm) and 
photographed.  
 
 
3.1.3 Plasmid isolation  
 
Plasmid isolation was done from 3-4 ml of bacterial cell (12-16 h at 37°C) using Wizard-Mini 
preps kits. 
 
3.1.4 Photometric determination of DNA concentration 
 
The absorption of nucleic acid solution was measured at 260 nm. The nucleic acid 
concentration was calculated using the following equation: c [µg/µl] = E260 * f * (dilution), f 
= 0.02 (for oligonucleotides, ss-DNA, RNA), f = 0.04 (for ds-DNA, plasmids). 
 
 
3.1.5 DNA digestion with restriction enzymes 
 
Double stranded DNA molecules were digested with 1-5 U of the restriction enzyme per µg 
of DNA at the optimal temperature (usually 37°C) in the buffer recommended by the supplier. 
If digestion was done with two or more enzymes, the most compatible buffer was used. In 
case that it was not possible to do double digestion, enzymes were used one by one with 
purification steps in-between. Purification steps were done with the Nucleotrap-Kit. 
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3.1.6 DNA extraction from agarose gels 
 
DNA bands were cut from the agarose gel with a scalpel. Afterwards DNA was extracted with 
the Nucleotrap-Kit (Marcherey-Nagel) following the manufacturer’s instructions. 
 
 
3.1.7 Generation of DNA blunt ends 
 
After PCR or restriction digestion, the Klenow fragment of DNA-polymerase I was used to 
make DNA ends blunt. For one Klenow reaction 7.2 µl DNA (1-2 µg), 0.8 µl Klenow enzyme 
[1U/µl], 1 µl 10× Klenow buffer and 1 µl dNTPs [1 mM] was used and incubated for 45 min 
at 37°C. After this reaction DNA was purified using the Nucleotrap-Kit. 
 
 
3.1.8 5'-DNA-phosphorylation 
 
Treatment of DNA with the Klenow fragment or PCR results in strands without 5’-phosphate 
groups. For ligation these fragments need to be phosphorylated. One reaction contains 1-2 µg 
DNA (or all Klenow reaction), 1 mM ATP, 7 U T4-Polynucleotid kinase and 10× kinase 
buffer. The reaction was incubated at 37°C for 45 min.  
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3.1.9 5'-DNA-dephosphorylation 
 
To avoid recirculation of blunt-ended plasmid DNA after EcoR V digestion, the 5΄-
phosphates were removed with calf alkaline phosphatase. 1-2 µg DNA were incubated with 
0.2 U alkaline phosphatase in phosphatase buffer at 37°C for 45 min. 
 
 
3.1.10 Ligation of DNA fragments 
 
DNA fragments were ligated with DNA ligase, using the Rapid DNA Ligation Kit according 
to the supplier’s instructions. The optimal vector/insert ratio was assumed to be 1:3. 
 
 
3.1.11 Purification of DNA by precipitation with ethanol 
 
To precipitate DNA from solution 1/10 of the total volume 3 M Na-acetate (pH 4.5) and 2 
volumes of 98.9% ice-cold ethanol were added and stored at -20°C for 1 h. Afterwards the 
sample was centrifuged for 15 min at 12000 × g and 4°C. The supernatant was discarded and 
the pellet was washed with 750 µl of 70% ethanol. After centrifugation for 10 min at 12000 × 
g and 4°C the supernatant was again discarded and the pellet was dried in a vacuum 
centrifuge for 5 min.  
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3.1.12 DNA Sequencing 
 
DNA sequencing was done using the Thermo Sequenase fluorescent labelled primer cycle 
sequencing kit (Amersham) with 7-deaza-dGTP. The DNA template was cycled together with 
a 5΄-fluorescent sequencing primer. For one sequencing reaction 1 µg plasmid DNA, 2 pmol 
of primer and 0.7 µl 3% DMSO were used (13 µl total volume). 3 µl of this DNA-primer 
were added to 2 µl of each G/A/T/C reaction mixture. Finally, one drop of low melting wax 
was added to each sample. The sequence reaction was done in a PCR block using the 
following temperature protocol (Table 3.2): 
 
 
 
 
Denaturation 95°C 5 min 
Denaturation 95°C 20 s 
Annealing 56°C 20 s 
30 
cycles 
Extension 70°C 20 s 
                                   
                           Table 3.2 Temperature program used for DNA sequencing  
 
 
After adding 5 µl of formamide loading dye provided with the kit the samples were loaded on 
a 6% polyacrylamide gel. DNA electrophoresis and detection was done with a LI-COR DNA 
Sequencer model 4000 with TBE as a running buffer. BaselmagelIR V. 4.0 software (MWG-
Biotech) was used for analysis. 
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3.2 Cloning strategies 
 
 
3.2.1 Vectors used 
 
3.2.1.1 pBluescriptII SK (-) vector 
 
 
 
 
 
 
 
 
 
3.2.1.2 pOG1/2 vectors 
 
 
 
 
 
 
 
pOG1/2
Amp r
ColE1 origin
pOG1
BamH I
Hind III
Cla I
Sma I
Kpn I
EcoR I
Xho I
Xba I
Sph I
Aat II
pOG2
Aat II
Sph I
Xba I
Xho I
EcoR I
Kpn I
Sma I
Cla I
Hind III
BamH I
T7 promotor
β-globin
5‘ Sequence
β-globin
3‘ Sequence
Poly A/ poly C
T3 promotor
Not I
pBluescript II SK (-)
2961 bp
Amp r
ColE1 origin
Kpn I
Apa I
Xho I
Sal I
Cla I
HinD III
EcoRV
EcoRI
Pst I
Sma I
BamH I
Spe I
Xba I
Not I
Sac II
Sac I
LacZ
Lac promotor
F1 (-) origin
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3.2.1.3 myc-pOG2 vectors 
 
 
 
 
 
 
 
 
 
 
3.2.1.4 pQE-30 vector 
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I
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I
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I
Xm
a
I
Sa
l I
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t I
H
in
d
III
Amp r
ColE1 origin
PT5 lac O lac O RBS ATG 6xHis MCS Stop codon
*
*
ggatccgcatgcgagctcggtaccccgggtcgacctgcagccaagctt aattagctgagatg agaggatcg
EcoR I RBS
RGS-His epitope
6xHis BamH I   Sph I      Sac I      Kpn I    Sma I   Sal I       Pst I        HinD III
Xma I
t0
pQE-30
Ba
m
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I
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I
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I
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I
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I
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I
Sa
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Ps
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H
in
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III
myc-pOG2
Amp r
ColE1 origin
T7 promotor
β-globin
5‘ Sequence
β-globin
3‘ Sequence
Poly A/ poly C
T3 promotor
Not I
EcoR I
HinD III
myc-tag
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3.2.2 Cloning strategy of the PfAQP E125S/F190Y mutant 
 
The PfAQP E125S mutant in the pOG1 vector was used as a template for a PCR reaction, with 
primer PfAQP F190Yas to introduce a F190Y mutation. This resulted in a PfAQP E125S/F190Y 
mutation. The length of the PCR product was 624 bp. After the purification by agarose gel 
electrophoresis, the PCR product was purified from the agarose gel, treated with Klenow 
enzyme and 5’ phosphorylated. The purified blunt end PCR product was cloned into 
pBluescript II (SK-) via the EcoR V site (Fig. 3.1).  
Via EcoR I/BamH I restriction sites the PCR product was ligated into the pOG1 vector 
containing PfAQP mutant (PfAQP M24I). By this procedure, the M24I mutant was replaced by 
the double mutant PfAQP E125S/F190Y. 
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Fig. 3.1. Schematic presentation of cloning strategy of PfAQP E125S/F190Y mutant 
 
 
3.2.3 Cloning of the PfGAPDH open reading frame into the pQE-30 expression vector 
 
To amplify the PfGAPDH ORF, P. falciparum (strain Binh1) genomic DNA was used (Fig. 
3.2). The PfGAPDH ORF contains an intron. To avoid the intron two PCRs were carried out. 
The first product contained the full length ORF including the intron and the  
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one the part downstream of the intron. Both PCR products were cloned into pBluescript II 
SK(-). Afterwards, the PCR product containing the full ORF was cloned into pQE-30 via Sph 
I/HinD III and was digested afterwards with EcoR V and Hind III restriction enzymes. By this 
digestion only the first 86 bp PfGAPDH remained in the pQE-30 vector. Finally, the second 
PCR product (after the intron) was equally digested with EcoR V and Hind III restriction 
enzymes and ligated into the pQE-30 vector with the first 86 bp of PfGAPDH to complete the 
full length open reading frame. 
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Fig. 3.2. Schematic presentation of cloning strategy of PfGAPDH  
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3.2.4 Cloning strategy of the Toxoplasma gondii aquaporin  
 
The TgAQP open reading frame has two potential start methionines at positions M1 and M39.  
T. gondii genomic DNA was used for TgAQP M1 and TgAQP M39 PCR amplification. 
Condition for the PCR for both TgAQP M1 and TgAQP M39 were identical (Fig.3.3). The 
length of the PCR products was 821 bp and 733 bp, respectively. After electrophoresis, the 
separated fragments were purified, treated with Klenow fragment and finally 5’ 
phosphorylated. The blunt ended fragments were then cloned in pBluescript II SK(-) vector 
via the EcoR V site. After this first cloning step, cloning into pOG2 vector was done. The 
pOG2 and myc-pOG2 vectors and TgAQP DNAs were digested with EcoR I/HinD III 
restriction enzymes and ligated. 
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Fig. 3.3. Schematic presentation of cloning strategy of TgAQP M1 and TgAQP M39 open reading frames 
in pOG2 vector. 
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3.3 Microbiological methods 
 
 
3.3.1 Competent cells 
 
5 ml of LB medium were inoculated with a single bacterial colony (XL1-blue MRF-or BL21 
(DE3) [pREP4]) and incubated over night at 37°C at 200 rpm. 1 ml of the culture was 
transferred into 50 ml fresh LB medium and incubated at 37°C (200 rpm) until an OD600 of 
0.3-0.4 (approximately 2-3h) was reached. The culture was cooled on ice for 10 min and 
centrifuged at 2500 × g for 20 min at 4°C. The pellet was re-suspended in 10 ml ice cold 
CaCl2 (0.1 M), incubated on ice for 20 min and centrifuged once more (2500 × g, 20 min, 
4°C), the pellet was re-suspended in ice cold 0.1 M CaCl2 supplemented with 20% glycerol 
and incubated on ice for 2 h. 100 µl aliquots were stored at -80°C. 
           
 
3.3.2 Transformation of competent E. coli cells 
 
The DNA ligation reaction (20 µl) was diluted with 10 µl 10 × CM buffer (100 mM CaCl2, 
100 mM MgCl2) and 70 µl sterile water. This was added to 100 µl competent cells, mixed 
gently and then incubated on ice for 25 min. Cells were heat shocked at 42°C for 50 sec. 
Afterwards, cells were incubated on ice for 10 min and 500 µl of LB medium were added. 
This mixture was incubated for 45 min at 37°C (200 rpm). 200 µl of the mixture was spread 
on LB agar plates with appropriate antibiotics. Plates were incubated in an inverted position 
for 12-16 h at 37°C.  
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The transformation with the pBluescript II SK (-) vector could be monitored by a blue-white 
screen by spreading 40 µl of IPTG (0.1 M) and 40 µl of X-Gal (2 %) on the LB agar plate 
prior to cell plating. Bacteria carrying pBluescript with recombinant DNA formed white 
colonies, those carrying a plasmid without an insert formed blue colonies.  
 
 
 
3.4 Protein expression in Xenopus laevis oocytes 
 
 
3.4.1 Oocyte preparation 
 
A X. laevis female frog was anesthetised in 500 ml Tricain solution (1g/l) and afterwards the 
oocytes were isolated by making a 1 cm long incision on the left or right ventral side. A part 
of the ovarian sack was removed and oocytes were placed in ND96 medium. Oocytes were 
washed in OR-2 medium and incubated in collagenase solution (0.5 mg/ml in OR-2) for 20-
30 min (200 rpm). The oocytes were washed in ND96 medium and selected under the 
microscope (stage V and VI). 
 
 
3.4.2 cRNA synthesis 
 
The in vitro synthesis of cRNA was done with T7 RNA-polymerase using the 
mMESSAGEmMACHINE-Kit (Ambion). 1-5 µg of Not I linearised pOG1/2 plasmid in a 20  
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µl reaction mixture was incubated for 2 h at 37°C. After digestion of DNA with 1 µl, 2 U/µl, 
DNAse I for  15 min at 37°C cRNA was precipitated by addition of 25 µl 7.5 M LiCl for 60 
min at -20°C. The precipitate was centrifuged, washed with 70% ethanol, dried in a vacuum 
centrifuge (5 min) and dissolved in 25 µl RNAse free water. The concentration of synthesised 
RNA was measured photometrically and diluted to a final concentration of 100 ng/µl.  
 
 
3.4.3 Oocyte injection 
  
Oocyte injection was performed under the microscope with a nano-liter injector. The oocytes 
were injected with 50 nl of distilled water or 50 nl of cRNA solution (100 ng/µl). Injected 
oocytes were incubated at 15°C for 3-4 days. 
 
 
3.4.4 Standard oocyte swelling assay 
 
To measure water permeability, oocytes were abruptly placed in 1:3 times diluted ND96 
medium. To measure solute permeability 65 mM NaCl in ND96 was exchanged with 130 mM 
a non-ionic compound (e.g. glycerol, dihydroxyacetone, methylglyoxal). The isosmolality of 
ND96 medium was checked with a osmometer (Knauer) (± 10 mosm/kg). Oocyte swelling 
assays were performed under the microscope at room temperature and monitored with a 
camera connected to a computer, where all calculations were done. From the change in oocyte 
surface the change in relative volume (V/V0) was calculated. Using the following formula, 
water Pf [µm s-1] (1) and solute Ps [µm s-1] (2) permeability are calculated.  
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Pf  =  V0 · d(V/V0)/dt / [S · Vw · (osmin – osmout)]      (1) 
 
V0 = 9 · 10-4 cm3 (initial oocyte volume), d(V/V0)/dt (relative volume increase in s-1), S = 
0.045 cm2 (oocyte surface area), Vw molar water volume (18 cm3 mol-1) and osmotic gradient 
(osmin – osmout) 
 
                        
Ps = [osmtotal · V0 · d(V/V0)/dt] / [S · (solout – solin)]   (2) 
 
osmtotal = 300 mOsm (total osmolarity of the system), V0 = 9 · 10-4 cm3 (initial oocyte 
volume), d(V/V0)/dt (relative volume increase in s-1), S = 0.045 cm2 (oocyte surface area), and 
(solout – solin) = 130 mOsm (osmotic solute gradient). 
 
 
3.5 Protein chemistry methods 
 
 
3.5.1 Protein expression in Xenopus laevis oocytes 
 
P. falciparum aquaporin (PfAQP), T. gondii (TgAQP M1, TgAQP M39) aquaporins, T. 
brucei aquaporins (TbAQP1, TbAQP2, TbAQP3), rat AQP3 and rat AQP1 were expressed in 
X. laevis oocytes after injection of 5 ng of cRNA and incubation at 16°C for three days. 
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3.5.2 Membrane protein preparation from Xenopus laevis oocytes 
 
For the preparation of membrane proteins 5 oocytes were lysed in 500 µl hypotonic phosphate 
solution and homogenised by pipeting up and down on ice. The homogenate was centrifuged 
for 5 min at 500 × g at 4°C. Afterwards the supernatant was collected. Further, the 
supernatant was centrifuged for 30 min on 17000 × g at 4°C, the yolk on the top of the 
supernatant was soaked away with paper and the rest of supernatant was removed by pipeting. 
The pellet was resuspended in protein sample buffer and solubilised at 37°C for 1 h and stored 
at -20°C for later use in Western blots. 
 
 
3.5.3 Plasmodium falciparum glyceraldehyde-3-phosphate dehydrogenase (PfGAPDH) 
expression in E. coli 
 
For expression of PfGAPDH a pre-culture was made with E.coli BL21 [rep4] cells containing 
the plasmid with the PfGAPDH gene. Therefore, 5 ml of LB medium supplemented with 50 
µg/ml kanamycin and 100 µg/ml ampicillin were inoculated with E. coli BL21 [rep4]  cells 
and incubated over night at 37°C (210 rpm). The overnight culture was inoculated into 200 ml 
of LB medium supplemented with 50 µg/ml kanamycin and 100 µg/ml ampicillin. Protein 
expression in E.coli BL21 [rep4] cells was induced at an OD600 of 0.6 with 1 mM isopropyl-β-
D-thiogalactoside (IPTG). After 14 h of incubation at 37°C the cells were harvested at 3000 x 
g for 10 min. Cell pellets were then stored at -80°C. 
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3.5.4 Purification of PfGAPDH 
 
The cell pellet from 1 l culture was  resuspended in lysis buffer (300 mM NaCl, 50 mM Tris-
HCl, pH 8.0) and lysed using a French press. The particulate fraction was removed at 27,000 
x g and the soluble, recombinant PfGAPDH protein was bound to 300 µl Ni-NTA agarose 
(Qiagen) for two hours on ice. After washing with 2 ml 50 mM Tris-HCl buffer pH 8 
supplemented with 300 mM NaCl, 10 mM DTT and 1 mM NAD+, then with the same buffer 
(2 ml) supplemented with 10 mM and 30 mM imidazole, respectively, the PfGAPDH protein 
was eluted in 2 ml (300 mM NaCl, 150 mM imidazole, 10 mM DTT, 1 mM NAD+, 50 mM 
Tris-HCl, pH 8.0) and dialyzed against assay buffer (300 mM NaCl, 1 mM NAD+, 50 mM 
Na2HPO4, 10 mM DTT, 50 mM Tris-HCl pH 8.0). Purified PfGAPDH protein was stored at 
room temperature at a concentration of 3 mg/l. 
 
 
3.5.5 Determination of protein concentration using the Bradford method  
 
1-10 µg of protein were pipetted to 800 µl distilled water and mixed. 200 µl of Bradford 
(BioRad) Dye Reagent Concentrate (5×), were added and mixed, and the absorbance was 
measured at 595 nm. The protein concentration was calculated using a BSA calibration curve. 
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3.5.6 Preparation of membrane proteins from Plasmodium falciparum blood culture 
 
The erythrocytes were collected from 1 ml of blood culture (hematocrit 5%). 50 µl of the 
erythrocyte pellet were lysed in 4 volumes of phosphate buffer. The mixture was 
homogenised on ice by gently pipetting up and down. The mixture was centrifuged at 4°C for 
30 min at 17000 × g. The supernatant was discarded, the pellet was washed twice with the 
same buffer and afterwards the pellet was suspended in 100 µl of sample buffer and incubated 
for 1 h at 37°C. 
 
 
3.5.7 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
 
SDS-PAGE electrophoresis was done using the Hoefer apparatus. In table 3.3 the recipe of 
polyacrylamide gels are shown:  
 
 
Stacking gel  4% Running gel  12.5% 
Stacking gel buffer 0.5 ml Running gel buffer   1.5 ml 
Water 1.2 ml Water      2 ml 
AA/Bis (37.5%):(1%) 0.3 ml AA/Bis 37.5(%):1(%)   2.5 ml 
TEMED    5 µl TEMED      5 µl 
APS 10%  20 µl APS 10%    40 µl 
 
        Table. 3.3. The volumes of ingredients used for SDS-polyacrylamide gel 
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Protein samples were mixed with sample buffer and heated at 95°C for 5 min (PfGAPDH) or 
at 37°C for 1h (AQPs) before loading on a 12.5% gel. Electrophoresis was done at a constant 
current: 20 mA, 200 V for 45-60 min. Gels were stained with Coomassie Blue for 30 min 
with gentle agitation and afterwards destained or used unstained for electrotransfer for 
Western blotting. 
 
To estimate protein size peqGold Marker was used Table 3.4: 
 
peqGold Marker MW (kDa) 
Lyzozyme 14.4 
β-lactoglobulin 18.4 
RE Bsp981 25 
Lactate dehydrogenase 35 
Ovalbumin 45 
BSA 66 
β-lactoglobulin 116 
               
                    Table3.4 The list of proteins and their sizes used for SDS-PAGE electrophoresis 
 
 
3.5.8 Western blot 
 
After SDS-PAGE, Western blot was done using the Semi-Dry-Electrotransfer and a PVDF 
membrane which was activated in methanol for 5 min. One 3 mm Whatman paper was soaked 
in Blot buffer, placed on the anode and gently pressed to remove air-bubbles. Then, the 
activated PVDF membrane was placed on the paper. On top of the PVDF membrane the SDS-
PAGE gel was placed. One soaked 3 mm Whatman paper was placed on top. Again,  
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air-bubbles were removed. At the end, the cathode was placed on the top and transfer was 
carried out with a current of 2-3 mA/cm2 of gel (20 V) for 2-3 h. After the transfer the gel was 
stained with Coomassie Blue for 30 min. The PVDF membrane was stained with Ponceau S 
for 5 min. When the proteins were visible the membrane was washed with deionized water 
and photographed. Afterwards, the membrane was incubated for 1 h in blocking solution (M-
TBS buffer). Then, the membrane was incubated for 1 h with the primary antibody diluted in 
M-TBS buffer. After washing (1 x 15 min, 2 x 5 min) the membrane was incubated with the 
secondary antibody diluted in M-TBS buffer for 1 h. Washing was repeated. For 
chemoluminiscence a mixture of 2 ml of solution A and 50 µl of solution B of the ECL-Plus 
Western Blotting Detection Kit was prepared. The mixture was uniformly distributed over the 
surface of the membrane and incubated for 5 min. Afterwards, a film exposure with 
Hyperfilm-ECL was taken. Exposure periods varied from 5 sec to 5 min. 
 
 
 
3.6 Culture of blood stage Plasmodium falciparum and purification of 
genomic DNA 
 
P. falciparum parasites (strains Binh1  and 3D7) were cultivated at 5% hematocrit (O+ 
bloodtype) and 0.5-5% parasitemia  in RPMI 1640 medium supplemented with 25 mM 
HEPES, 20 µg/ml gentamicin sulphate, 2 mM glutamine, 200 mM hypoxanthine, and 0.5% 
Albumax II at 37°C in a nitrogen atmosphere (90% N2, 5% O2 and 5% CO2) (Trager et al., 
1976).  
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3.6.1 Synchronisation of erythrocytic stage of Plasmodium falciparum parasites 
 
For synchronisation with sorbitol parasites should be in the ring stage (not longer than 10-12 
h). Everything was done under sterile conditions.  
The parasite culture (10 ml) was centrifuged at 600 × g at room temperature for 5 min. The 
supernatant was discarded and then 10 ml of 5% sorbitol were added to the red cell pellet.The 
suspension was mixed gently with a pipette and left for 5 min at room temperature. 
Afterwards, the cells were collected (600 × g, 5 min), washed twice with complete RPMI 
1640 medium. After 6 h the procedure was repeated (Lambros et al., 1979). 
      
 
3.6.2 Giemsa staining of thin blood films from parasite cultures 
 
The staining of malaria parasites was done by a standard procedure described in “Methods in 
Malaria Research” (Inger Ljungstöm et al., 2004). Shortly, thin blood films on slides were 
fixed in methanol for 30 s. After fixation, the slides were dried and stained in 10% Giemsa 
solution in phosphate buffer (pH 7.1) for 20 min. After staining, the slides were washed and 
analysed using a microscope at 100× magnification.    
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3.6.3 Plasmodium falciparum culture in medium supplemented with glycerol  
  
Here, RPMI 1640 medium with and without glucose supplemented with 11 mM glycerol was 
used for the culture. Starting parasitemia was 0.2%, parasites in the ring stage were 
synchronized with sorbitol. The total culture volume was 5 ml, hematocrit 5%. Every day a 1 
ml sample was taken, the cells were collected (600 × g, 5 min) and frozen at -20°C. Medium 
was changed every day after taking the samples. Samples cultivated in complete RPMI 1640 
medium were used as controls.  
 
 
 
3.7 Monitoring of Plasmodium proliferation by ELISA 
 
A commercial ELISA based on the quantitation of the P. falciparum histidine rich protein 2 
(HRP2) was used (Malaria Ag CELISA, Cellabs; Noedl et al., 2002). Briefly, 96-well plates 
were pre-dosed with 10 µl of dihydroxyacetone, methylglyoxal, glycerol, glucose, 
chloroquine, fosmidomycin and ammonium chloride dilutions in complete RPMI 1640 
medium. Synchronized parasite cultures (80% rings) were diluted to 0.05% of parasitemia at a 
hematocrit of 1.5%. Then, 90 µl of the diluted cultures were added to each well of the pre-
dosed plates. After 72 h of incubation at 37°C in 90 % nitrogen atmosphere the plates were 
harvested and twice freeze-thawed. The samples were transferred to ELISA plates, and 
analyzed according to the Cellabs protocol using an ELISA plate reader at 450 nm. 
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3.8 GAPDH enzyme assay 
 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyzes the following reaction: 
glyceraldehyde-3-phosphate + NAD+ + Pi                      1,3-bisphosphoglycerate + NADH + H+ 
The initial conversion rate of NAD+ is measured as an increase in absorption at 340 nm. One 
unit is defined as the amount of enzyme that converts one micromole NAD+ per minute at 
25°C. 
The assay was done in Tris-HCl buffer (50 mM, pH 8.0), supplemented with 300 mM NaCl, 
50 mM Na2HPO4, 1 mM NAD+ and recombinantly expressed PfGAPDH (5 µg/ml) or 
commercially available rabbit GAPDH (5 µg/ml). The reaction was started at room 
temperature by the addition of 360 µM DL-glyceraldehyde-3-phosphate.  
 
 
3.9 Quantification of ammonia in the culture medium 
 
Glutamate dehydrogenase (GLDH) catalyzes the conversion of α-ketoglutarat to L-glutamate 
in the presence of NH4+ and NADPH.  
NH4+ + α-ketoglutarat + NADPH                 L-glutamate + NAD+ + H2O 
The reaction was followed at 340 nm until the end point was read. 
The assay was done in 122 mM TEA buffer pH 8.0 supplemented with 300 µl sample, 0.56 
mM ADP, 71 mM α-ketoglutarat, 6 mM NADPH. After 5 min the reaction was started by 
addition of GLDH to a final concentration of 7.4 U/ml.  
From the differences in absorption before and after the reaction the ammonium concentration 
was calculated based on a calibration curve with known ammonium concentrations.
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4 Results 
 
 
4.1 Modulation of water and glycerol permeability of the Plasmodium 
falciparum aquaglyceroporin by introducing a mutation in the pore 
constriction region  
 
It has been suggested that the electrostatic environment at the extracellular pore entry of the 
P. falciparum aquaglyceroporin may regulate water permeability (Beitz et al., 2004). An 
E125S mutation introduced in the conserved WET triad in the extracellular C-loop of PfAQP 
affected water permeability while glycerol permeability was changed only minimally. It was 
proposed that by removing the charge at position 125 and thus probably disrupting an 
interaction of Glu125 with Arg196, the polarity of the constriction region would change. The 
pore layout of PfAQP E125S closely resembles that of GlpF, i.e. E. coli aquaglyceroporin with 
high glycerol and low water permeability. 
During the course of this work I addressed the question whether the water permeability of 
PfAQP E125S could be improved again by introducing an additional mutation at the pore 
constriction region.  I sought to mimic the AQP3 pore layout which contains a Tyr instead of 
the Phe present in GlpF (Phe200) and PfAQP (Phe190). AQP3 is an aquaglyceroporin with 
good glycerol and intermediate water permeability. Mutating Phe190 of PfAQP to tyrosine 
would introduce an additional hydroxyl group and increase polarity in pore constriction 
region (Fig. 4.1.).  
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Fig. 4.1. Schematic presentation of the PfAQP, AQP3 and GlpF pore constriction region. 
 
 
4.1.1 Expression and characterisation of PfAQP E125S/F190Y  
 
To test this hypothesis I generated the double mutant PfAQP E125S/F190Y. This variant as well 
as PfAQP wild type were expressed in oocytes and characterised in standard oocyte swelling 
assays. 
PfAQP E125S/F190Y cRNA was injected into X. oocytes and protein expression was analysed 
by Western blot using a specific PfAQP antibody (Fig. 4.2.).                                                     
 
 
 
 
 
 
 
 
Fig. 4.2. Western blot analysis of PfAQP wt and PfAQP E125S/F190Y expressed in X. laevis oocytes with 
anti-PfAQP antibody (on the SDS-PAGE gel 1.2 oocyte per line was loaded). 
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Osmotic swelling assays showed that the PfAQP E125S/F190Y variant was water permeable. 
However, compared to wild type PfAQP (316 µm s-1) its water permeability (28 µm s-1) was 
11 times smaller (Fig.4.3. A). 
PfAQP E125S/F190Y (0.55 µm s-1) also showed glycerol permeability. Still, glycerol 
permeability was 3 times smaller than that of PfAQP wt (1.63 µm s-1; Fig. 4.3. B). 
The expression levels of PfAQP wt and PfAQP E125S/F190Y were not equal (Fig. 4.2.). To 
avoid the influence of expression level on oocytes permeability results, the ratios between 
water and glycerol in wild-type and mutant were calculated. The water/glycerol ratio for 
PfAQP wt is 194:1, and for the PfAQP E125S/F190Y it is 51:1 (Fig. 4.3. C). Comparing these 
data to those of the published PfAQP E125S mutation, where water permeability was reduced 
to background level, with the double mutant water permeability was gained.  
 
 
 
 
 
 
 
 
 
 
 
Fig.  4.3. Water and glycerol permeability of PfAQP wt and PfAQP E125S/F190Y mutant. 
A: water permeability Pf  [µm s-1] of PfAQP wt and PfAQP E125S/F190Y. B: glycerol permeability Ps [µm s-1]. 
Control values for water (37 µm s-1) and glycerol (0 µm s-1) were subtracted from the sample values. C: 
water/glycerol ratio for PfAQP wt and PfAQP E125S/F190Y. All values are mean ± S.E.M. (n=5-6). 
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4.1.2 pH dependency of water permeability in PfAQP 
 
Since a glutamate residue seems to be responsible for the high water permeability of PfAQP I 
wanted to test for a pH effect on water and glycerol permeability of the PfAQP.  Shifts to low 
pH may change the protonation status of Glu125 and may alter permeability properties. The 
pKa value of the carboxyl group in glutamic acid is 4.4. As it is known pKa values depend on 
temperature, ionic strength and microenvironment. Amino acid pKa values in proteins might 
be different than in solution because of the influence of other amino acids and the 
environment. 
To test water permeability a pH-range of pH 3-7 was used. For glycerol permeability I used a 
broader range of pH values from pH 3 to pH 9. The basic condition at pH 9 can led to amino 
acid deprotonation and may influence the possible interaction between Glu125 and Arg196. 
Swelling assays at the different pH values were performed with oocytes expressing PfAQP. 
The data show that water permeability Pf (Fig. 4.4. A) was not dependent on the pH in the 
range tested. Glycerol permeability was not significantly changed at different pH values, too 
(2p>0.05; Fig. 4.4. B). 
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Fig. 4.4. Water and glycerol permeability of PfAQP at different pH values.  A: Pf values for water 
permeability at different pH values.  B: Ps values for glycerol permeability different pH values. All values are 
mean ± S.E.M. (n=5-6). (control values for water (9, 6, 6,10, 21µm s-1) and glycerol (-0.018, -0.01, 0.024, 0.141 
µm s-1)  at different pH values were subtracted from sample values. Two control values for glycerol have 
negative values because of oocyte shrinking). 
 
 
 
4.2 Glycerol induction of PfAQP expression in Plasmodium falciparum 
blood culture 
 
The physiological functions of PfAQP are unknown. It has been reported that parasites utilize 
serum glycerol to synthesise glycerolipids (Vial et al., 1975). Hansen et al. proposed that 
glycerol may be used as a backup energy source in P. falciparum in hypoglycaemia states 
when glucose uptake is restricted (Hansen et al., 2002).  
After phosphorylation and oxidation glycerol could enter glycolysis. Further, glycerolipid 
synthesis using glycerol from the host should be favoured by the parasite over generating  
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glycerol from glucose due to the resulting shift in the NAD+/ NADH ratio towards the 
oxidized form. 
There are examples that glycerol content in the serum regulates aquaporin expression in 
humans (Carbrey et al., 2003). Expression of AQP9 in the hepatocyte plasma membrane is 
induced up to 20 fold when glycerol levels rise. AQP9 is permeable to glycerol and urea and 
to a wide range of different solutes including polyols, carbamides, purines, pyrimidines, 
nucleosides and monocarboxylates (Tsukaguchi et al., 1998).  
After in vitro characterisation of PfAQP I moved to an in vivo parasite system and tested for 
glycerol induction of PfAQP expression in P. falciparum blood culture.  
Parasite growth and expression levels of two cultures were analysed, one without glycerol and 
one with 11 mM glycerol supplementation (Fig. 4.5. A). Starting parasitemia was 0.2% with 
the parasites in the ring stage. After two days, parasitemia increased 4-5 fold and after five 
days 25-30 fold. Addition of glycerol led to an 8 fold increase of the PfAQP protein 
expression (Fig. 4.5. B). However, parasites did not survive in medium where glucose was 
replaced by glycerol. Apparently, plasmodia cannot use glycerol as the only energy source 
(Fig. 4.6).   
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Fig. 4.5. Influence of glycerol on parasite proliferation and PfAQP expression. A. Growth curves of P. 
falciparum parasites in medium without (open squares) and with 11 mM (filled squares) glycerol addition. B. 
Western blot with samples taken after three days of parasite culture with  and without glycerol (control). 
 
 
 
 
 
 
 
 
 
Fig. 4.6.  Growth curves of P. falciparum parasites in medium supplemented with glucose (filled circles) or 
glycerol (filled squares) as an energy source. 
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4.2.1 Ammonia permeability of PfAQP 
 
One of the central features in malaria metabolism is digestion of the host cell cytosolic 
proteins (predominantly haemoglobin) to be used as a source of amino acids for protein 
biosynthesis (Francis et al., 1997).  
Protein biosynthesis and degradation is accompanied by the production of cytotoxic ammonia. 
Further, P. falciparum deaminates and oxidises glutamine to gain reduced NADH. One 
biochemical way of detoxification is to convert ammonia to urea. This detoxification process 
is accomplished in the urea cycle by most terrestrial vertebrates. In the plasmodia genomes, 
none of the enzymes of the urea cycle, except arginase, have been detected. 
Alternatively, ammonia could be exported from a cell by ammonium transporters but these do 
not seem to be present in the Plasmodium genome. Ammonia diffusion through the membrane 
could occur, but the question is, would it be sufficient?  
It was reported that a yeast strain lacking ammonium transporters could not grow if the only 
nitrogen source is ammonium chloride (5 mM). When the ammonium ion concentration is 
increased to 20 mM then yeast cells grow (Marini et al., 1997). Some aquaporins like plant 
aquaporins and human AQP8 were characterised as ammonia channels (Janh et al., 2004; 
Holm et al., 2005).  
PfAQP as an aquaglyceroporin is also a good candidate for an ammonia channel. A yeast 
strain lacking all ammonia transporters and the endogen aquaporin Fps1 was used as an assay 
system to test ammonia permeability and indeed, it turned out that PfAQP facilitates ammonia 
permeation (Wu, personal comunication).  
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4.2.2 Ammonia production in Plasmodium falciparum parasites 
 
To test ammonia production in parasites I used standard culturing conditions (Trager et al., 
1976) with highly synchronised parasites (more than 85% were in ring stage). Starting 
parasitemia was 5%, total culture volume was 20 ml. Samples (1 ml) were taken at 0, 16, 24, 
38, 48 and 64 h and ammonia was quantified. After each time point, bottles were gassed and 
again incubated at 37°C until the next sample was taken. 
Non-infected erythrocytes were used as a control.  Ammonia production in non-infected 
erythrocytes was absent, but in culture with parasites ammonia production was detected after 
16 h. (Fig. 4.7).  
Between 16 and 24 h there is a sudden increase in ammonia production in parasites. This time 
interval corresponds to the trophozoites developmental stage of P. falciparum. After 16 h 
parasites were in the trophozoite stage. 
 
 
 
 
 
 
 
 
 
Fig. 4.7. Ammonia production in P. falciparum clone 3D7 culture (filled circles) and in non-infected 
erythrocytes (open circles). Ammonia levels in RPMI 1640 medium were subtracted from ammonia levels in 
parasite and erythrocytes samples. (n=3 ± S.E.M.) 
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The parasitemia between 16 and 24 h was 5%, hematocrit 5%. Ammonia production at this 
time point was 175 µmol/l corresponding to 2.75*1010 infected red blood cells (IRBC). The 
amount of ammonia produced by one parasite per hour was 0.8 fmol/parasite. Accordingly, 
one litre of IRBC produce 8.8 mmoles of ammonia per liter of triphozoite infected cells per 
hour whereas lactate production is 220 mmoles (one litre of packed erythrocytes contains 
1.1*1013 cells). Thus, there is 20 times less ammonia production than lactate production in 
plasmodia (Ginsburg et al., 2002).  
 
 
4.2.3 Effect of ammonia on growth of Plasmodium falciparum parasites 
 
An ELISA was used to test growth of P. falciparum 3D7 in medium supplemented with 
various concentrations of NH4Cl. Ammonium chloride was toxic for plasmodia 3D7 clone 
with an IC50 of 2.8 mM (Fig. 4.8.).  
The parasite volume is 20 fl in the trophozoite stage. If ammonia is not transported out from 
the cell in 4.2 min the concentration of ammonia in the parasite cell might reach 2.8 mM.  
Thus, parasites live on the edge of death. 
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Fig. 4.8. Effect of ammonium chloride on growth of P. falciparum 3D7 clone.  The IC50 for ammonium  is 2.8 
mM (n=2 ± S.E.M.). 
 
 
 
4.3 Dihydroxyacetone and methylglyoxal permeability of PfAQP and AQP3  
 
Except for water and glycerol, PfAQP is permeable for other uncharged solutes, such as 
polyols of up to five carbon-hydroxyls in length (Hansen et al., 2002). 
Carbonyl containing compounds have not been tested before. Dihydroxyacetone (DHA) is a 
three carbon sugar with one keto group at the C-2 atom and methylglyoxal (MG) is a three-
carbon compound with a keto and an aldehyde group.  
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Dihydroxyacetone can be metabolised in glycolysis after phosphorylation to 
dihydroxyacetone phosphate. Non-phosphorylated DHA is cytotoxic as shown with a yeast 
strain that lacks both endogenous DHA kinases. Non-enzymatic and enzymatic elimination of 
phosphate from dihydroxyacetone phosphate leads to formation of methylglyoxal. 
Methylglyoxal is a physiological substrate of the glyoxalase system which catalyses the 
conversion of methylglyoxal to D-lactate (Phyllips et al., 1993). Efficient conversion of 
methylglyoxal to D-lactate via the glyoxalase system protects the cell from the highly reactive 
and toxic methylglyoxal.  
PfAQP and the red cell aquaglyceroporin, AQP3, were tested for dihydroxyacetone and 
methylglyoxal permeability. Isosmotic swelling assays with oocytes expressing PfAQP and 
AQP3 were done in isosmotic glycerol, DHA or MG solution (130 mM; Fig. 4.9. A and B). 
Oocytes expressing water specific AQP1 were used as controls. From the swelling curves the 
solute permeability coefficients Ps were calculated. The glycerol permeability of PfAQP (0.49 
µm s-1) was two times higher compared to that of AQP3 (0.29 µm s-1), DHA permeability was 
similar for both aquaglyceroporins, (PfAQP 0.32 µm s-1, AQP3 0.28 µm s-1). PfAQP showed 
permeability for MG (0.29 µm s-1) in the same range as with DHA, but AQP3 was not 
permeable for MG (Fig. 4.9. C). 
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Fig. 4.9. Permeability of PfAQP and AQP3 for glycerol, dihydroxyacetone and methylglyoxal. A: The 
relative oocyte volume increase in oocytes expressing PfAQP in a 130 mM glycerol (circles) or dihydroxyactone 
(squares) or methylglyoxal (triangles) gradient. B: Swelling curves of oocytes expressing AQP3 in a isosmotic 
chemical gradient (130 mM) for glycerol (circles) or dihydroxyactone (squares) or methylglyoxal (triangles) 
gradient C: Solute permeability (Ps ) calculated from the initial slope of the oocytes swelling curves (n=4-10 ± 
S.E.M.). Control oocytes were injected with AQP1 cRNA and control values for glycerol (-0.077 µm s-1), DHA 
(-0.034 µm s-1) and MG (-0.03 µm s-1) were subtracted from measured values. 
 
 
 
4.4 Influence of dihydroxyacetone and methylglyoxal on parasite growth  
 
Erythrocytes can use DHA as an energy source (Taguchi et al., 2002). Triose kinase 
phosphorylates one hydroxyl group of dihydroxyacetone. As a phosphorylated compound it 
can enter glycolysis.  Using BLAST search I could not identify any triose kinase in P. 
falciparum genome.  
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To test the influence of DHA on parasite growth the Binh1 strain was used. Culturing was 
done in standard medium supplemented with different concentration of DHA (0, 1, 2.5, 5, 10 
mM). Parasite cultures were synchronised with sorbitol (Lambros et al., 1979), starting 
parasitemia was 0.5% and parasites were in ring stage.  
Parasitemia was counted every day for four days and for each DHA concentration. To 
estimate parasitemia 5000 erythrocytes of each sample were counted. Cultures which had 
been treated with 5 and 10 mM DHA, did not proliferate at all. A culture which had been 
treated with 2.5 mM DHA, showed 20% lower parasitemia than the untreated control (Fig. 
4.10. B). 
Using the parasitemia values after four days I determined an IC50 of 3.3 mM DHA (Fig. 4.10. 
C). 
A 
 
 
 
 
 
 
 
 
   
 
 
 
 
Fig. 4.10. Effect of DHA on P. falciparum (Binh1) proliferation. A: Giemsa stained parasites after four days 
of treatment with DHA. B: Growth curves of P. falciparum cultured with DHA. C: Parasitemia values after four 
days are plotted as a growth inhibition curve. The IC50 for DHA is 3.3 mM. 
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The DHA effect on parasites was confirmed by an ELISA based on quantification of the 
constitutively expressed plasmodial histidine rich-protein II (Noedl et al., 2002).  
Starting parasitemia was 0.02%, hematocrit 1.5% and the samples were incubated at 37°C for 
three days. At the beginning of the experiment parasites were more than 85% in ring stage. It 
is important to have highly synchronised parasites because different compounds affect 
different developmental stages of parasites and by synchronization the effect of a compound 
can be followed easier.   
The DHA influence on parasite proliferation was tested on the Binh1 and the 3D7 strains. The 
3D7 clone is chloroquine sensitive contrary to Binh1. I tested the parasite proliferation of 
different DHA concentrations (0-10 mM). The IC50 for the Binh1 strain was 3.0 mM and for 
the 3D7 clone it was 2.6 mM. Parasite growth in samples which were treated with 5 and 10 
mM DHA, was fully inhibited (Fig. 4.11. A: open and closed circles).  
Both, Binh1 and 3D7 were also treated with MG (0-10 mM) and it turned out that this 
compound was 10-20 times more toxic to both parasite strains than DHA. The IC50 value for 
the 3D7 clone was 128 µM MG and for the Binh1 strain 223 µM MG (Fig. 4.11. B) 
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Fig. 4.11. Growth inhibition curves of P. falciparum clone 3D7 and Binh1 strain treated with 
dihydroxyacetone and methylglyoxal A: Growth inhibition curves of Binh1 (filled circles) and 3D7 (open 
circles) treated with DHA. IC50 values based on these curves are 3.0 mM (Binh1) and 2.6 mM (3D7 clone). B: 
Inhibitory effect of methylglyoxal on Binh1 and 3D7 clone growth. The IC50 values are 223 µM (Binh1, filled 
squares) and 128 µM (3D7, open squares; n=2-3, ± S.E.M.).  
 
To exclude the possibility that DHA and MG interact with erythrocyte membranes causing a 
decrease in parasite invasion or disturbing parasite intracellular metabolism I treated 
erythrocytes with up to 10 mM DHA and up to 2 mM MG.  I observed them for three days.  
However, presence of DHA and MG in the media did neither change the morphology of 
erythrocytes nor increase cell lysis. Pre-treated erythrocytes were washed to remove residual 
DHA and MG and then infected with plasmodia parasites. Growth and proliferation of 
parasites using these erythrocytes were not affected. This suggested that the mechanism of 
DHA and MG toxicity is not via host cell disturbance, but through direct interaction with the 
parasites. 
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4.5 Co-treatment of Plasmodia with dihydroxyacetone plus chloroquine and 
fosmidomycin 
 
Having found that DHA is toxic to parasite cells I became interested in the mode of toxicity. 
Since the early 1950s chloroquine has been widely used as an antimalarial drug. Chloroquine 
inhibits heme polymerisation in the food vacuole of plasmodia. Fosmidomycin has been used 
in clinical trials. Its mode of action is inhibition of the isoprenoid synthesis in the apicoplast. 
Co-treatment of parasites with DHA plus chloroquine or fosmidomycin may give hints on the 
mode of DHA toxicity. 
First the 3D7 clone was treated with DHA (0, 0.5, 1, 2, 5, 10 mM) in combination with 
chloroquine (0, 0.1, 0.3, 1, 3, 10, 30, 100 nM). The IC50 was 5 nM for chloroquine and 2.2 
mM for DHA with or without co-treatment. This indicates that both compounds act 
independently (Fig. 4.12. A and B) 
 
 
 
 
 
 
 
 
 
Fig. 4.12. A: Influence of different concentrations of dihydroxyacetone on chloroquine IC50 values. B: Effect of 
different concentrations of chloroquine on dihydroxyacetone IC50 values.  (n=3, ± S.E.M.). 
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To test DHA-fosmidomycin combinations DHA was used at 0, 0.5, 1, 2, 5, 10 mM and 
fosmidomycin at 10, 30, 100, 300, 1000, 3000, 10000 nM. The IC50 for DHA was 2 mM and 
for fosmidomycin 240 nM with or without co-treatment, indicating independent modes of 
action (Fig. 4.13. A and B). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.13. A: Influence of different concentrations of dihydroxyacetone on fosmidomycin IC50 values. B: Effect 
of different concentrations of fosmidomycin on dihydroxyacetone IC50 values (n=3, ± S.E.M.). 
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can modify proteins by irreversible modification of cysteine, lysine and arginine groups (Oya 
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4.6 Cloning and characterisation of PfGAPDH from Plasmodim falciparum 
strain Binh1 
 
P. falciparum glyceraldehyde-3-phosphate (PfGAPDH) dehydrogenase was cloned and 
expressed before (Daubenberger et al., 2000). I amplified the open reading frame from 
genomic DNA of P. falciparum strain Binh1. Sequencing of the complete open reading frame 
resulted in a single, probably strain specific mutation (C418A) compared to the published 
genome (www.plasmoDB.org; gene_ID 140598) leading to a Q140K change, but comparing 
with the sequence published by Daubenberger et al. there are two additional differences, 
P272L and I276V. 
 
 
 
4.6.1 Expression and purification of PfGAPDH 
 
The PfGAPDH gene was subcloned into the pQE30 vector with an N-terminal RGS-His6 tag 
and then expressed in E. coli. Expression yield was 3 mg of enzyme/litre cell culture. 
Coomassie staining was used to detect the purified protein (Fig. 4.14.).   
The PfGAPDH protein was unstable at 4°C and precipitation occurred within 24 h at 4°C, 
while at room temperature it was stabile for one week.  
 
 
 
 
 
Results 
 70
 
 
 
                                                                                                                      
 
 
 
 
 
Fig. 4.14. A: Ni2+-NTA purification of PfGAPDH. 1-pellet, 2-flow through, 3-wash with without imidazole, 4-
marker (12.5, 18, 25, 35, 45, 66, 116 kDa), 5-wash with 10 mM imidazole, 6-wash with 30 mM imidazole, 7-
elution with 150 mM imidazole, 8-elution with 600 mM imidazole. SDS-PAGE gel 12.5%. B: Western blot 
analysis of recombinant PfGAPDH. His-taged protein detected with anti-RGS-His6 antibody.  
 
 
 
4.6.2 GAPDH inhibition assay with dihydroxyacetone and methylglyoxal 
 
For inhibition assays PfGAPDH was incubated with 2.5 mM DHA and 200 µM MG, i.e. the 
IC50 values obtained in growth inhibition experiments. 200 µM MG did not have an influence 
on PfGAPDH activity. Thus, PfGAPDH and rabbit GAPDH were incubated at 37°C with 2.5 
mM MG and DHA. With DHA, rabbit GAPDH activity was instantly reduced to 60%, after 3 
h enzyme was fully inhibited. With MG, rabbit GAPDH activity decreased to 50% after 3 h 
and after 20 h the enzyme was fully inhibited (Fig. 4.15. A). PfGAPDH was more resistant to 
DHA and MG inhibition. After 3 h of incubation with DHA, activity was around 30% and 
after 6 h enzyme activity was fully inhibited. Incubation with MG did not have any inhibitory 
effect on PfGAPDH even after 20 h of incubation (Fig. 4.14. B). 
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Fig. 15. Influence of dihydroxyacetone and methylglyoxal on rabbit GAPDH (A) and on PfGAPDH (B) 
activity. Relative activity of enzymes treated with 2.5 mM DHA (circles) and 2.5 mM MG (squares) were 
plotted. (n=2 ± S.E.M.) 
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4.7 Toxoplasma gondii aquaporin (TgAQP) 
 
 
Besides P. falciparum, another human pathogenic parasite, i. e. T. gondii, belongs to the 
phylum Apicomplexa. P. falciparum multiplies exclusively in erythrocytes, whereas T. gondii 
invades various cell types.  
 
 
4.7.1 Identification of TgAQP 
 
Using BLAST searches I identified a single putative aquaporin gene in the T. gondii genome 
(TgAQP). The longest open reading frame is 792 bp. In the same reading frame two start 
codons are present, at nucleotide positions 1 and 115 which could translate into proteins 
TgAQP M1 (29.9 kDa) and TgAQP M39 (26.3 kDa) (Fig. 4.16. A). At position 13-99 an in-
frame intron with classical GT/AG boundaries may be located (gray shading in Fig. 4.16. A) 
Surprisingly, the TgAQP aquaporin had only 28% sequence similarity to PfAQP. Instead, 
TgAQP showed highest similarity to water-specific plant tonoplast intrinsic proteins (e.g. TIP 
2;1, 47%, Arabidopsis thaliana).The level of similarity between TgAQP, γ-TIP, AQP1 and 
GlpF is reflected by “Expected” (E) values from the BLAST analysis which vary by four 
orders of magnitude (Fig. 4.16. B). The pore forming residues around the canonical NPA 
motifs are highly conserved between TgAQP and γ-TIP channels including a valine at the 
pore constriction region where other aquaporins including AQP1 and GlpF almost exclusively 
have a positively charged arginine (Fig. 4.16. B).   
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E value
*
TgAQP 88  SGAHFNPAVS . . . AGATMNPAVT 205
γ-TIP 80  SGGHVNPAVT . . . SGASMNPAVA  203   3·10-9
AQP1 71  SGAHLNPAVT . . . TGCGINPARS 196 7·10-7
glpF 64  SGAHLNPAVT . . . TGFAMNPARD  207   3·10-1
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Fig. 4.15. Sequence analysis of TgAQP.  A: The open reading frame is shown with two potential ATG start 
codons. The canonical NPA sequences are shaded in black. An in-frame intron is possibly located at position 13-
99 (grey shaded). B: Part of the protein sequence alignment of prototypical aquaporins. In γ-TIP and in TgAQP 
the highly conserved arginine is exchanged by valine (marked with a star). The expected (E) value from a 
BLAST search with TgAQP as a query is indicated on the right.  
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4.7.2 Expression and functional characterisation of TgAQP transcripts 
 
Both TgAQP M1 and TgAQP M39 constructs were expressed in oocytes to determine 
whether they form functional pores.  
Initially, protein expression was checked in X. laevis oocytes. As shown by Western blots 
constructs of TgAQP M1 and TgAQP M39 with an N-terminal c-myc epitop tag were equally 
expressed (Fig. 4.16. A). Protein migration was lower than expected from the molecular 
weight calculation which is supposed to be 30 kDa and 26 kDa, respectively, but they were 
27.7 and 20.1. The blot further shows TgAQP dimers (arrows Fig. 4.17. A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.17. Immunoblots of myc-TgAQP M1 and myc-TgAQP M39 constructs expressed in X. laevis 
oocytes. A: The oocytes membranes were probed with anti-c-myc antiserum. Arrows show myc-TgAQP M1 and 
myc-TgAQP M39 dimmers. B: MW calculation curve, filed squares represent MW of marker and open squares 
represent MW of TgAQP M1 (27.7 kDa), TgAQP M39 (20.1) and dimers. 
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For functional characterisation, the amount of cRNA for injection and the incubation time was 
optimised.  
 
 
4.7.2.1 Optimisation of cRNA amount and incubation time 
 
X. laevis oocytes were injected with 1-10 ng of TgAQP M1 cRNA. During the course of four 
days oocytes were daily tested for water permeability. Expectedly, permeability was 
dependent on the amount of injected cRNA and increased with longer incubation time. After 
three days maximal water permeability was reached and only a minor difference between 5 ng 
and 10 ng of cRNA was noted. Thus, injecting 5 ng of cRNA and incubation for three days 
was used in the following for TgAQP M1 expression in the oocyte system (Fig. 4.18.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.18. Water permeability in oocytes injected with different amounts of TgAQPM1 cRNA during four 
days of incubation. Bars represent Pf values. Control values were subtracted from the sample values (15, 14, 18, 
18 µm s-1; n=5, ± S.E.M.). 
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4.7.3 Water and glycerol permeability of TgAQP M1 and TgAQP M39 
 
TgAQP M1 and TgAQP M39 water and solute permeability was compared to the previously 
characterised PfAQP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.19. Water and glycerol permeability of X. laevis oocytes expressing TgAQP M1, TgAQP M39 and 
PfAQP.  
A: Relative volume increase of X. laevis oocytes injected with cRNA for TgAQP M1 (filled circles), TgAQP 
M39 (open circles), PfAQP (squares) in 1:3 diluted medium during the first minute of swelling. B:  Pf values 
(mean ± S.E.M) were calculated from the swelling curves. C: Relative volume increase of X. laevis oocytes (co-
)injected with cRNA for TgAQP M1/AQP1 (filled circles) PfAQP/AQP1 (filled squares), TgAQP M1/AQP1 
(open circles). Relative volume change is shown for 1 min, in isotonic medium with 130 mM glycerol instead of 
65 mM NaCl. D: Ps values were calculated from swelling curves. All values are mean ± S.E.M. The number of 
oocytes is 5-8 in osmotic and 5 in isosmotic swelling assays. Control values for water (14 µm s-1) and glycerol 
(0.025 µm s-1) were subtracted from measured values. 
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Swelling curves taken after hypotonic shock of TgAQP M1, TgAQP M39 and PfAQP (Fig. 
4.19. A) showed that oocytes injected with PfAQP cRNA swelled faster compared to oocytes 
injected with TgAQP M1 and TgAQP M39 cRNA. The Pf value for TgAQP M1 (98.7 µm s-1) 
was three times smaller than that of PfAQP (311.2 µm s-1), and 3.5 times higher than TgAQP 
M39 (25.2 µm s-1; Fig. 4.19. B). Compared to the water permeability of PfAQP, the T. 
gondii aquaporin is a channel with intermediate water permeability. Given that PfAQP is a bi-
functional channel with both, high water and glycerol permeability (Hansen et al., 2002), 
TgAQP was tested for glycerol permeability. Swelling curves of TgAQP M1, TgAQP M39 
and PfAQP showed that oocytes injected with PfAQP and TgAQP M1 cRNA had a similar 
swelling rate (0.98 µm s-1, 0.77 µm s-1 respectively), but oocytes injected with TgAQP M39 
cRNA swell three times slower (0.25 µM s-1; Fig. 4.19. C and D). 
In summary, TgAQP M1 is a good glycerol channel with intermediate water permeability. 
 
 
4.7.4 Solute permeability of TgAQP 
 
As a characteristic of aquaglyceroporins, the solute permeability profile of TgAQP M1 was 
determined. Besides urea which passed the pore as well as glycerol, only erythritol and D-
arabitol led to reasonable swelling rates of about 25% compared to glycerol glycerol 
permeability. Larger compounds hardly passed the pore and myo-inositol and charged 
compounds did not pass at all (Fig. 4.20. A). 
It has been reported that proliferation of T. gondii parasites was inhibited by hydroxyurea. 
Thus I tested whether TgAQP may be involved in hydroxyurea delivery into the cell. Further,  
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I compared TgAQP hydroxyurea permeability to that of PfAQP. Indeed, the drug passed 
through both aquaglyceroporins with rates 75% of the glycerol permeability (Fig. 4.19. B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  4.20. Solute permeability of TgAQPM1 and PfAQP. Bars present Ps values calculated from swelling 
curves. For each calculation 5-6 oocytes were used. The error bars are ± S.E.M. 
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4.8 Trypanosoma brucei aquaporins (TbAQPs) 
 
T. brucei, the causative agent of sleeping sickness transmitted by the tsetse fly is a member of 
the genus Kinetoplastida. Effective drugs against sleeping sickness have not been found yet.  
 
4.8.1 Identification of Trypanosoma brucei aquaporins  
 
In collaboration with N. Uzcategui and M. Duszenko (Physiological Chemistry, Tübingen) 
three aquaporins were identified in the expressed sequence tags (ESTs) database of T. brucei. 
These three aquaporins were named TbAQP1, TbAQP2 and TbAQP3. TbAQP1 and TbAQP3 
have the canonical triads NPA/NPA and the highly conserved arginine after the second NPA 
motif. The TbAQP2 has some differences. The first canonical motif is NSA and the second is 
NPS and instead of the highly conserved arginine at the constriction site, leucine was found 
(Fig. 4.21. A). Sequence alignment and phylogenetic tree analyses suggested that these three 
aquaporins have more similarity to aquaglyceroporins (AQP3, AQP9, PfAQP, GlpF) than to 
aquaporins (AQP1, AQPZ) (Fig. 4.21. B). Prediction of amino acid content in the pore 
constriction region of TbAQPs was done using the crystal structure of E. coli GlpF. The only 
difference in TbAQP1 and TbAQP3 pore constriction region compared to GlpF are 
Tyr267(258) instead of Phe200 (Fig. 4.21. C). The predicted pore constriction region of 
TbAQP2 contains Ile109, Leu258 and Leu264 and the presence of un-polar amino acids 
suggests that the pore is wider than in GlpF and that it has similar composition as the pore 
constriction region of TgAQP (Fig. 4.21. C).  
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Fig. 4.21. Sequence analysis of T. brucei aquaporins.  A: Alignment of amino acid sequence of T. brucei 
aquaporins. Red shaded parts represent canonical NPA (TbAQP1 and 3)/NSA (TbAQP2), and second 
NPA(TbAQP1 and 3) /NPS(TbAQP2)  regions. The blue shaded region represents the conserved arginine in 
TbAQP1 and 3 and leucine in TbAQP2. B: Phylogenetic tree analysis of TbAQPs. C: The part of protein 
sequence alignment of TbAQPs and GlpF, in purpose to predict the structure of pore constriction region , based 
on crystal structure of E. coli GlpF. Underlined parts represent NPA/NSA and NPA/NPS regions, and red dots 
label possible amino acids in pore constriction region. 
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4.8.2 Water and glycerol permeability of TbAQPs 
 
After sequence analysis which suggested that these three aquaporins might be 
aquaglyceroporins, TbAQPs were tested for water and glycerol permeability. Oocytes 
expressing TbAQP1-3 swelled when exposed to hypotonic shock (Fig. 4.22. A). From the 
calculated Pf values for TbAQP1 (139 µm s-1), TbAQP2 (109 µm s-1), TbAQP3 (129µm s-1), 
these channels can be characterised as channels with intermediate water permeability between 
TgAQP M1 (98.7 µm s-1) and PfAQP (311 µm s-1; Fig. 4.22. B). 
The swelling rate in 130 mM glycerol gradient was similar among the TgAQPs (Fig. 
4.22. C). The Ps values were in the range of 0.9-1.2 µm s-1 which is comparable to the 
swelling rate of PfAQP (Fig. 4.22. D).  
In conclusion, all three TbAQPs are channels with intermediate water and excellent glycerol 
permeability. 
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Fig. 4.22. Water and glycerol permeability of X. laevis oocytes expressing TbAQPs. 
A: Relative volume increase of X. laevis oocytes injected with cRNA for TbAQP1 (squares), TbAQP2 (circles), 
TbAQP3 (triangles) in 1:3 diluted medium during the first minute of swelling. B: Pf values (mean ± S.E.M.) 
were calculated from the swelling curves. C: Relative volume increase of X. laevis oocytes (co-)injected with 
cRNA for TbAQP1/AQP1 (squares) TbAQP2/AQP1 (circles), TbAQP3/AQP1 (triangles). Relative volume 
change is shown for 1 min, in isotonic medium with 130 mM glycerol instead of 65 mM NaCl. D: Ps values were 
calculated from swelling curves. All values are mean ± S.EM. The number of oocytes is 5 in osmotic and 5 in 
isosmotic swelling assays. Control values for water (34 µm s-1) and glycerol (0.087 µm s-1) were subtracted from 
measured values. 
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The swelling rate of TbAQP expressing oocytes was measured in the presence of a variety of 
polyols, dihydroxyacetone, urea, pyruvate and alanine. Oocytes expressing TbAQPs were 
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D
TgAQP3
TbAQP2
TbAQP1
0.0 0.2 0.4 0.6 0.8 1.0 1.2
0 15 30 45 60
1.00
1.05
1.10
1.15
1.20C
re
l. 
vo
l.
time [s]
TgAQP3
TbAQP2
TbAQP1
0 50 100 150
B
0 15 30 45 60
1.00
1.05
1.10
1.15
1.20
water
140 mosm
A
re
l. 
vo
l.
time [s]
glycerol
130 mM
Pf [µm s-1] Ps [µm s-1]
re
l. 
vo
l.
re
l. 
vo
l.
 
 
Results 
 83
 
with about half the rate of glycerol. All TbAQPs were highly permeable for DHA, especially 
TbAQP2 with a swelling rate double that of glycerol. TbAQP1 showed a 1.5 fold higher 
swelling rate than for glycerol and TbAQP3 exhibited an equal swelling rate as glycerol. Urea 
passed the pores of TbAQP2 and TbAQP3 somewhat slower than glycerol but less well that 
of TbAQP1. Only TbAQP3 transported erythrytol and ribitol. Pyruvate passed only TbAQP2 
at a 8 times slower rate compared to glycerol (Fig. 4.23.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.23. Substrate permeability of X. laevis oocytes injected with TbAQPs cRNA. The bars represent Ps 
values calculated from swelling curves. (n=4-5, ± S.E.M.). 
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5 Discussion 
 
 
5.1 Importance of the C-loop in water permeability 
 
As a complementary study to the already published data on molecular dissection of water and 
glycerol permeability of the PfAQP by mutational analysis (Beitz et al., 2004), here, 
additional mutants were generated. 
Although there is an equal amino acid composition in the pore constriction region in PfAQP 
and GlpF of E. coli, they have different water permeability. Both aquaglyceroporins are 
glycerol permeable, but PfAQP additionally has a high water permeability.  
The PfAQP as an extraordinary aquaglyceroporin was used to study water permeability in 
aquaglyceroporins. This work showed that the C-loop has an important role in water 
permeability, precisely Glu125 (Beitz et al., 2004). The mutation E125S dramatically reduces 
water permeability. I succeeded in improving the relative water permeability by making the 
double mutant PfAQP E125S/F190Y.  By introducing F190Y mutation the polarity in the pore 
constriction region was increased. Composition of the pore constriction now resembled the 
aquaglyceroporin AQP3. The presented data suggest that the polarity in the pore constriction 
region and the possible interaction of C-loop with arginine at the same region might be 
important for water permeability. 
 
 
 
 
Discussion 
 85
 
5.2 The influence of different pH values on water and glycerol permeability 
 
The results show that pH shifts between 3 and 7 have no influence on water and glycerol 
permeability of PfAQP. The idea that low pH values might influence the protonation of 
Glu125 in the C-loop could not be demonstrated. An explanation can be that the Glu125 is not 
solvent exposed. 
 
5.3 PfAQP as a conductor for dihydroxyactone and methylglyoxal 
 
Except for water and glycerol aquaporins can be permeable to many other solutes such as C3-
C6 polyols and urea (Hansen et al., 2002), ammonia (Jahn et al., 2004), carbon dioxide 
(Cooper et al., 1998), arsenite (Liu et al., 2002). In mammals, aquaporins are expressed in 
many epitelia involved in water transport, as well as in cell types which are not predominantly 
involved in water transport such as skin, or in glycerol transport in hepatocytes and 
adipocytes. 
The complete energy metabolism in Plasmodium parasites relies on glucose utilisation. The 
end product of glucose consumption under anaerobic condition is lactate. Parasitized red 
blood cells produce 30 times more lactate than uninfected erythrocytes (Vander Jagt et al., 
1990). The metabolism of glucose is accompanied to D-lactate production. D-lactate  
production of the parasites appears to be a defence mechanism to protect the parasite from the 
toxic methylglyoxal. Formation of methylglyoxal via dihydroxyacetone 3-phosphate as a 
spontaneous side-reaction of glycolysis becomes physiologically relevant (Vander Jagt et al., 
1990). Methylglyoxal as a compound with a keto and an aldehyde group (4.3) is highly 
reactive and can covalently modify many proteins or even DNA. 
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DHA can be used as an energy source in erythrocytes after phosphorylation but in its 
dephosphorylated form it can be toxic. Apparently, plasmodia cannot utilize DHA, possibly 
due to the lack of a triose kinase.  
I showed that PfAQP is permeable to DHA and MG, i.e. two new potentially cytotoxic 
compounds that permeate aquaporins. They are added to the list of other cytotoxic permeants 
like arsenite and ammonia.  
The permeability of PfAQP for cytotoxic metabolites hints at multiple roles of this 
aquaglyceroporin possibly in the disposal of compounds which might be harmful for the 
parasite cell. 
Human AQP3, a member of the erythrocyte cell membrane is permeable to DHA but not to 
MG. DHA is a more polar and more flexible compound compared to MG due to specific 
structural differences in carbon atom hybridization. In DHA, only C2 is sp2 –hybridized 
whereas in MG there are two vicinal sp2 –hybridized carbons which makes MG a strict 
hydrogen bond acceptor. DHA might be both, donor and acceptor. This may explain different 
permeabilities of these compounds which are similar in size, but carry different structural 
properties. 
DHA and MG have an inhibitory effect on parasite growth (4.4). Both compounds are highly 
reactive, and the mode of action might be due to modification of a broad range of proteins.  
The obligate dependence of plasmodia on glycolysis for ATP production suggests that the 
enzymes of the glycolytic pathway can be used as drug targets (Roth et al., 1988; Dobeli et 
al., 1990).  
It was reported that after prolonged treatment of rabbit GAPDH, the key enzyme in 
glycolysis, with MG in the micromolar range might be inhibited (Lee et al., 2005). The  
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function of PfGAPDH was fully inhibited after 6 h of treatment with 2.5 mM DHA at 37°C, 
but MG did not have influence on PfGAPDH activity. An explanation for this might be 
hidden in differences in the molecular flexibility of these two compounds. DHA, as a more 
flexible one, might be able to approach a lysine near the active centre of PfGAPDH better 
than the rigid structure of MG. The active site of PfGAPDH seems to be more protected than 
that of rabbit GAPDH because of an insertion of two amino acids Lys194-Gly195. The 
treatment of rabbit GAPDH with 2.5 mM DHA and MG turned out to be different compared 
to PfGAPDH. Rabbit GAPDH was inhibited by both compounds. Inhibition with DHA was 
immediate, and slower with MG (complete after 20 h).  
Due to the high metabolic flux in plasmodia, there is a high production of MG. Additional 
supplementation of this compound might overwhelm the defence mechanism and thus be 
lethal for the parasites. DHA may preferentially act on GAPDH. When the concentration of 
DHA rises too high this compound might enter the parasite cell and modify GAPDH.  
Consequently, glycolysis is stopped. 
Further, the modification of PfGAPDH by DHA may lead to a rise in glyceraldehyde 
phosphate concentration, then the accumulation of this compound may increase the 
spontaneous formation of cytotoxic MG. 
In conclusion, small compounds might be used as potential drugs against malaria. However, 
DHA needs to be used in a concentration which is most likely to high to be applied as the 
possible drug. 
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5.4 Characterisation of the Toxoplasma gondii aquaglyceroporin 
 
In the T. gondii genome I found only one aquaporin. According to sequence analysis, TgAQP 
has similarity to plant TIP aquaporins. The layout of the pore constriction region is similar to 
TIP 1;1, especially the presence of a valine instead of the highly conserved arginine.  
Inspection of the genome of T. gondii showed the presence of plant derived genes in it. 
TgAQP may be additional evidence for the hypothesis that the phylum Apicomplexa 
originated from an eukaryotic ancestor which acquired a plastid by secondary endosymbiosis 
probably from an alga. 
TgAQP has intermediate water permeability, and rather surprisingly good glycerol 
permeability. The plant TIP aquaporins are exclusive water channels. Obviously, TgAQP 
glycerol permeability was gained afterwards.  
In the TgAQP open reading frame a possible intron was identified (4.8.1) with classical 
GT/AG boundaries. The water/glycerol permeability ratio of both possible ORFs TgAQP M1 
and TgAQP M39 is the same. The length of the C-terminal part of TgAQP did not influence 
the water/glycerol ratio. Testing the permeability of different solutes to estimate the size of 
the TgAQP pore region, TgAQP was mainly permeable for C3 polyols and barely for myo-
inositol which is a C6 cyclic compound. This aquaporin has also high permeability for urea. 
This information led to idea to test hydroxyurea, an anti-neoplastic compound. TgAQP had 
good permeability to this anti-neoplastic and toxic agent and may thus represent a path 
through which parasites take up this drug. Hydroxyurea is a new compound added to the list 
which pass aquaporins. 
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5.5 Characterisation of Trypanosoma brucei aquaglyceroporin 
 
The characterisation of T. brucei aquaporins (TbAQP1-3) showed that the TbAQPs are 
glycerol transporters with intermediate water permeability in the range of TgAQP and good 
glycerol permeability in the range of AQP3 and PfAQP. The permeability for different solutes 
was tested too, an intriguing finding is that all three aquaporins have good permeability for 
DHA which is even better than the permeability for glycerol. 
TbAQPs are differently expressed (Uzcategui et al., 2004) in different life cycle stages. The 
TbAQP1 is expressed in all phases (logarithmic, static phase in the host blood and in the 
insect procyclic form). Highest expression of TbAQP1 is during the static phase and it is the 
only aquaporin expressed in the procyclic form. TbAQP2 is scarcely expressed in all 
developmental phases where TbAQP2 was detectable only in the blood stream forms of the 
parasite. 
One characteristic of the static phase is glycerol production, and glycerol needs to be exported 
out of the glycosome because it suppresses ATP production. TbAQP1 is the best glycerol 
conductor of the three aquaporins expressed in T. brucei. Its physiological function might thus 
be in protection of parasites from detoxification. 
Further, DHA turned out to be toxic for T. brucei parasites as it is for plasmodia parasites. 
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5.6 Comparison of the constriction regions of parasite aquaporin pores 
 
Functional characterisation of T. gondii and T. brucei aquaporins showed that these channels 
are water and glycerol permeable. Comparing water and glycerol permeability of these 
aquaporins to PfAQP, glycerol permeability is similar for all of them but PfAQP has 
strikingly high water permeability. The amino acid composition at the pore entry determined 
pore selectivity for water and glycerol (solutes) (Tajkhorshid et al., 2002; Beitz et al., 2004). 
According to the crystal structures of aquaglyceroporin GlpF (Fu et al., 2000) and orthodox 
aquaporin1 (Walz et al., 1997), the narrowest pore constriction is located in the pore entry 
region. Thus the amino acid composition in the pore constriction region of TgAQP1 and 
TbAQP3 is similar to GlpF. The only difference is some additional polarity introduced by the 
p-hydroxy group of Tyr267 and Tyr250, respectively, in TgAQP1 and TbAQP3 instead of 
Phe200 in GlpF (Fig. 5.1). The introduction of a polar hydroxyl group in the pore constriction 
region of TbAQP1 and TbAQP3 might allow water to enter the channel better whereas GlpF 
has low water permeability (Borgnia et al., 2001). The pore layout of TgAQP1 and TgAQP3 
is thus identical to the human AQP3, i.e. an aquaglyceroporin with intermediate water and 
good glycerol permeability.  
The amino acid composition in the pore constriction region of TgAQP and TbAQP2 is similar 
to the plant TIP1;1 aquaporin. The main characteristic of these plant aquaporins is the 
presence of a valine instead of a highly conserved arginine. TgAQP and TbAQP2 are both 
water and glycerol permeable aquaporins whereas the TIP1;1 has only water permeability. 
The presence of His55 in the pore constriction region of TIP1;1 might be responsible for the 
exclusion of glycerol permeability by rendering the pore smaller and more polar. In TbAQP2  
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an isoleucine is present at this position which might make more room for a glycerol molecule 
to pass.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.1Schematic presentation of the GlpF, TbAQP1-3, PfAQP, TgAQP, TIP 1;1 and human AQP1 pore 
constriction region 
 
 
It appears that PfAQP has the widest pore. It allows polyols up to 5 C atoms in back bone to 
pass. On the first sight, TgAQP aquaporin pore looks wide, it contains Leu204, Ile73 and 
Ala198 in the pore narrowest region but C5 polyols barely pass the pore. Similar results were 
obtained with TbAQPs. Surprisingly, even in the case of TbAQP2, the permeability to urea is 
very low compared to the other protozoan aquaporins.  
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 However, a simple size selection mechanism cannot explain the differences in water 
permeability observed within the orthodox aquaporins. The distribution of polarity at the pore 
constriction region might be responsible for the rate of water flux through an aquaporin 
channel. The polarity at the pore mouth region of the E. coli GlpF is strongly concentrated on 
Arg206, in PfAQP the polarity of the Arg196 may be neutralised by Glu125 and in orthodox 
aquaporins such as in AQP1 the polarity of the pore is enhanced by the histidine residue 
(Beitz et al., 2004). 
 
 
5.7 Possible physiological functions of protozoan aquaporins 
 
The Toxoplasma, Trypanosoma and Plasmodium parasites are exposed to a high selective 
pressure and need to adapt to different environments. The transmission of the parasite from 
the vector to the mammalian host and passage through the kidneys are situations in which the 
osmotic stress might be coped by water-passing aquaporins. 
Aquaglyceroporins may be linked to glycolysis, i.e. the main energy source in protozoan 
parasites.  
During the aerobic stage of the Trypanosoma life cycle, glycerol can be used as an energy 
source (Ryley et al., 1962). In the anaerobic phase glycerol is formed from the glycerol-3-
phosphate by glycerol kinase and one ATP molecule is made. Glycerol molecules have to be 
quickly removed from the cytosol otherwise the production of ATP is decreased or stopped. 
Addition of 5 mM glycerol to the medium fully inhibits the glycerol growth (Bakker,  
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2000). This approach was tried as a treatment against T. brucei, however unsuccessful. When 
the treatment with glycerol was stopped, it came to a rebound.  
During infection with P. falciparum serum glycerol levels in the host rise from 20-60 µM to 
more than 200 µM (Pukrittayakamee et al., 1994). One fifth of the infected persons develop 
hypoglycaemia. Here, glucose levels drop down to 2.2 mM what is less than half compared to 
normal glucose levels (4-6 mM).  
It was shown that serum glycerol is used by plasmodia for lipid biosynthesis (Vial, et al., 
1989). Hansen et al. (2002) hypothesized that the glycerol which enters the parasite cell 
through the PfAQP, becomes phosphorylated by glycerol kinase and is used for glycerolipid 
synthesis. Glycerol-3-phosphate might be oxidised to dihydroxyacetone phosphate and further 
be used in glycolysis.  
My results showed that parasites cannot use the glycerol as the sole energy source. But the 
addition of glycerol in 11 mM concentration into the medium induced PfQAP expression, 
probably the glycerol was used for lipid biosynthesis. 
In the liver, glycerol 3-phosphate is generated by direct phosphorylation of glycerol while in 
the muscles and adipocytes, it is generated by reducing dihydroxyacetone phosphate with 
NADH. In adipocytes and muscles, glycerol-3-phosphate dehydrogenase (GPDH) 
(EC.1.1.1.8) is found in the cytosol and another GPDH (EC. 1.1.99.5) using FAD as a 
coenzyme is responsible for the reverse reaction of glycerol 3-phosphate to dihydroxyacetone 
phosphate in mitochondria (Kozak et al., 1974; Kuri-Harcuch et al.; Garrib et al., 1986). The 
Arabidopsis thaliana contains both NAD+ and FAD+ dependent GPDH. However, the NAD+ 
dependent GPDH is less likely to play a role in glycerol dissimilation as the equilibrium 
constant favours the synthesis of glycerol 3-phosphate (Eastmond et al., 2004). P. falciparum 
GPDH is still not characterised, but it might be that the reduction of  
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DHAP is favoured by the GPDH and it might be the reason why glycerol cannot be used as an 
energy source.  
 
Due to the high protein degradation in the parasite food vacuole, high level of toxic ammonia 
might be produced. Secondly, the parasite medium is in reached with 2 mM L-glutamine, 
which might be source of ammonia too. The rate of ammonia production in 1 l parasite 
culture is 0.022 mmoles per hour. In 4.2 min parasites can reach IC50 value of ammonium 
toxic concentration and further production without excreation of toxic compounds might lead 
parasites to death. 
 The possible causes of ammonia toxicity might be in changing the pH value in food vacuole, 
as the week base it can rise, the pH value and inhibit the proteases. Rapid export of toxic 
ammonia is needed. Thus, PfAQP is a good candidate for ammonia export from the cell.  
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5.8 Remaining questions  
 
The physiological function of characterised Plasmodium, Toxoplasma and Trypanosoma 
aquaporins is still uncertain. Knocking-out the genes of aquaporins in these parasites might 
give an answer whether these aquaporins are important for parasite survival or whether they 
are needed under stress. Immunochemical localisation of protozoan aquaporins might be 
helpful too. 
The crystallisation of these protozoan aquaporins can give a better picture of the structural 
impact in water and glycerol permeability and this may ultimately lead to novel approaches in 
anti-protozoan therapy.  
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6 Summary  
 
P. falciparum, T. gondii and T. brucei parasites cause infectious diseases that affect more than 
300-400 million people world-wide and, thus, represent a major health problem. The rapid 
spreading of drug resistant parasite strains initiated the search for new drug targets. 
Aquaporins at the parasite host interface have the potential to be used as a novel targets. 
I characterised biochemically a single T. gondii aquaporin (TgAQP) which has only 28% 
sequence similarity to the P. falciparum aquaporin (PfAQP) and 47% sequence similarity to 
water specific plant aquaporins (TIP 1;1) and three T. brucei aquaporins (TbAQP1-3) which 
show 40-45% similarity to mammalian AQP3. 
The pore constriction region of TgAQP has a valine instead of a highly conserved arginine.  
This exchange is rather typical for above-mentioned plant aquaporins. Thus, it supports the 
hypothesis that apicomplexans have plant ancestors. TbAQP1 and 3 have a similar amino acid 
composition in the pore constriction as AQP3. TbAQP2, however, has a leucine instead of the 
pore arginine, and NSA and NPS motifs instead of the canonical NPA motifs. 
I established that TgAQP and the TbAQPs are bifunctional pores with high glycerol and 
intermediate water permeability whereas in PfAQP both, water and glycerol permeability are 
high. 
Further testing of TgAQP permeability showed that besides urea, which passes the pore 
equally well as glycerol, only erythritol and D-arabitol reasonably permeate TgAQP. Other 
larger and/or charged compounds do not pass. Strikingly, hydroxyurea, an anti-neoplastic  
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agent with an inhibitory effect on parasite proliferation, could be identified as a permeant of 
TgAQP.   
Solute permeability TbAQPs is more restricted. Only TbAQP3 passed erythrytol and ribitol 
well. TbAQP2 showed permeability for pyruvate. All TbAQPs passed urea. 
The TbAQPs and PfAQP were further highly permeable for dihydroxyacetone (DHA). I could 
show that DHA is toxic for plasmodia parasites (IC50 2.5 mM). PfAQP was also tested for 
methylglyoxal (MG) permeability. MG is a side product of glycolysis and has a similar 
structure as DHA. MG was conducted by PfAQP and showed a toxic effect on malaria 
parasites (IC50 200 µM). P. falciparum glyceraldehydes phosphate dehydrogenase 
(PfGAPDH) was fully inhibited by 2.5 mM DHA after 6 h whereas MG did not have an 
inhibitory effect. Rabbit GAPDH as a control was fully inhibited by DHA after 3 h and by 
MG after 20h.  
In addition, PfAQP is permeable for ammonia. I showed that one liter of packed plasmodia 
red cells produces 8.8 mmol of ammonia of ammonia per hour. PfAQP may thus be vital for 
malaria parasites as a pathway for ammonia release.
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7 Zusammenfassung 
 
P. falciparum, T. gondii und T brucei Parasiten verursachen Infektionskrankheiten, die mehr 
als 300-400 Millionen Menschen auf der Welt betreffen und stellen ein großes 
Gesundheitsproblem dar. Die schnelle Ausbreitung von resistenten Stämmen löste die Suche 
nach neuen Angriffspunkten für Medikamente aus. Aquaporine im Membransystem zwischen 
Parasit und Wirt könnten als neue Angriffspunkte für Medikamente genutzt werden.  
In der vorliegenden Arbeit wurden ein Aquaporin aus T. gondii (TgAQP) sowie drei 
Aquaporine aus T. brucei (TbAQP1-3) biochemisch charakterisiert. 
TgAQP zeigt 28% Sequenzähnhichkeit  zu dem Auqaglyceroporin aus P. falciparum (PfAQP) 
und 47% Sequenzähnhichkeit zu wasserspezifischen Pflanzenaquaporinen (TIP 1;1). 
TbAQP1-3 weisen 40-45% Ähnhichkeit zu AQP3 aus Säugern auf. 
In der Porenregion von TgAQP, befindet sich ein Valin anstelle eines hochkonservierten 
Arginins. Dieser Aminosäurenaustausch ist typisch für die TIPs der Pflanzen und stützt die 
Hypothese, dass Apicomplexa pflanzliche Vorfahren haben. TbAQP1 und 3 haben eine 
ähnliche Aminosäurenzusammensetzung der Porenregion wie AQP3 und NPA Motive in der 
Region, die den Porenengpass bildet. TbAQP2 bildet eine Ausnahme, da es ein Leucin 
anstelle des Arginins hat und NSA und NPS Motive aufweist. 
Es wurde gezeigt, dass TgAQP und TbAQPs bifunktionale Poren sind, die durch eine hohe 
Permeabilität für Glycerin und eine mittlere Wasserpermeabilität gekennzeichnet sind. PfAQP 
hingegen hat eine hohe Permeabilität für sowohl Glycerin als auch Wasser. 
Die weitere Untersuchung der Permeabilität von TgAQP ergab, dass neben Harnstoff, der die 
Pore ebenso gut wie Wasser passiert, auch Erythritol und D-Arabitol eine gewisse  
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Durchgängigkeit besitzen. Für andere Verbindungen, die größer und/oder geladen sind, ist 
TgAQP nicht durchlässig. Interessanterweise kann Hydroxyharnstoff, ein anti-neoplastischer 
Wirkstoff, der die Parasitenproliferation inhibiert, durch die Pore dringen. 
Die Solutleitfähigkeit der TbAQPe ist eingeschränkt. Nur TbAQP3 lässt Erythritol und 
Ribitol pasieren. TbAQP2 hat eine geringe Permeabilität für Pyruvat. Alle TbAQPe sind 
permeabel für Harnstoff. 
Sowohl die TbAQPs als auch PfAQP haben eine hohe Durchlässigkeit für Dihydroxyaceton 
(DHA). Es wurde nachgewiesen, dass DHA für die Plasmodienparasiten toxisch ist (IC50 2,5 
mM). PfAQP wurde positiv auf Permeabilität von Methylglyoxal (MG) getestet. MG ist ein 
Nebenprodukt der Glykolyse und hat eine ähnliche Struktur wie DHA. Das von PfAQP 
eingeschleuste DHA wirkte toxisch auf die Malariaparasiten (IC50 200 µM). Des weiterem 
wurde die Auswirkung von 2,5 mM  DHA bzw. MG auf P. falciparum Glycerolaldehyd-
Dehydrogenase (PfGAPDH) untersucht. PfGAPDH wird nach 6 h vollständig von DHA 
inhibiert, wohingegen MG keinen inhibitorischen Effekt zeigt. Als Kontrolle wurde GAPDH 
aus dem Kaninchen verwendet, das von DHA nach 3 h und von MG nach 20 h vollständig 
inhibiert wird. 
PfAQP ist auch durchlässig für Ammoniak. Es wurde gezeigt, dass ein Liter gepackter 
malariainfizierter Erythrozyten 8,8 mmol Ammoniak pro Stunde produzieren. PfAQP könnte 
demnach überlebenswichtig für Plasmodien sein und als Anlass für Ammoniak 
fungieren.
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